Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Bronwen E. Shaw MD, PhD

Bronwen E. Shaw MD, PhD profile photo picture

Center Director, Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Medicine Hematology Oncology

Director of the Center for International Blood and Marrow Transplant Research (CIBMTR)
Member of the Cancer Center

View Curriculum Vitae

Publications (312)

  • Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort. (Shaffer BC, Al Malki MM, Jimenez AMJ, Stanek J, Bo-Subait S, Logan BR, Kou J, Leckrone E, Stefanski HE, Spellman SR, Malmberg C, Askar M, Cusatis R, Modi D, Khimani F, Hamadani M, Maiers M, Cook R, Ballen K, Bolaños-Meade J, Rao U, Milner J, Abboud R, Jamieson K, Carrum G, Dholaria B, Hogan WJ, Reshef R, Kosuri S, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Auletta JJ, Shaw BE, Devine SM, Gooptu M) Am J Hematol 2026 Nov;101(11):2827-2835 PMID: 42674730 PMCID: PMC13656881 SCOPUS ID: 2-s2.0-105048940816 08/31/2026    
  • Umbilical Cord Blood Donor Outcomes in BMTCTN1702. (Bashey A, Lee SJ, Devine SM, Shaw BE, Dehn JG, Pidala JA, Hogan WJ) Blood Adv 2026 Aug 28 PMID: 42664501 08/28/2026    
  • Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: results from the ACCESS trial. (Jimenez Jimenez AM, Stanek J, Logan BR, Leckrone E, Stefanski HE, Auletta JJ, Spellman SR, Malmberg C, Askar M, Cusatis RN, Shaffer BC, Modi D, Khimani F, Gooptu M, Hamadani M, Maiers M, Bo-Subait S, Bolaños-Meade J, Rao U, Milner J, Abboud R, Jamieson KJ, Carrum G, Dholaria B, Hogan WJ, Reshef R, Kosuri S, Cook RJ, Ballen K, Loren AW, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Shaw BE, Devine SM, Al Malki MM) Blood Adv 2026 Aug 19 PMID: 42616616 08/19/2026    
  • Challenges With Expansion of Cell and Gene Therapy: A Call for System-Level Action. (Auletta JJ, Urbano-Ispizua A, Maziarz RT, Shaw BE, Sureda A, Vasu S, Porter DL) Transplant Cell Ther 2026 Aug 12 PMID: 42586370 PMCID: PMC13537614 SCOPUS ID: 2-s2.0-105049335730 08/12/2026    
  • Infection burden in mismatched unrelated donor hematopoietic cell transplantation: results from the ACCESS trial. (Auletta JJ, Stanek J, Bo-Subait S, Al Malki MM, Cook R, Gooptu M, Shaffer B, Jimenez AJ, Modi D, Hill JA, Huppler AR, Kou J, Cusatis R, Broglie L, Shaw BE, Stefanski H, Spellman SR, Devine SM) Blood Adv 2026 Oct 13;10(19):6551-6563 PMID: 42448319 PMCID: PMC13634427 SCOPUS ID: 2-s2.0-105051395330 07/15/2026    
  • Donor-specific transplant outcomes from BMT CTN 1702: a multicenter prospective biologic assignment trial. (Bashey A, Logan B, Hill L, Symons H, Farhadfar N, Grunwald MR, Pidala J, Dehn JG, Brunstein C, Arai S, Leifer E, He N, Shaw BE, Juckett M, Devine S, Uberti J, Westervelt P, Srour SA, Pusic I, Vasu S, Hayes-Lattin B, Ciurea SO, Horowitz MM, Lee SJ, Hogan WJ) Blood Adv 2026 Aug 25;10(16):5543-5552 PMID: 42263667 PMCID: PMC13482518 SCOPUS ID: 2-s2.0-105047220932 06/10/2026    
  • Hematopoietic Cell Transplant Access and Patient Diversity. (Cusatis R, Kou J, Bupp C, Mattila D, Abboud R, Arai S, Bolaños Meade J, Carrum G, Dholaria B, Fareh F, Hamadani M, Hogan WJ, Jamieson K, Jimenez Jimenez AM, Khimani F, Kelkar AH, Kosuri S, Larkin KT, Al Malki MM, McCurdy SR, Milner J, Modi D, Reshef R, Shaffer BC, Shanmugasundaram K, Rao U, Auletta JJ, Devine SM, Logan BR, Shaw BE) JAMA Netw Open 2026 May 01;9(5):e2610839 PMID: 42084866 PMCID: PMC13147192 SCOPUS ID: 2-s2.0-105038059420 05/05/2026       2 Citations
  • Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacy. (Shaffer BC, Shaw BE) Curr Opin Immunol 2026 Jun;100:102783 PMID: 42060959 PMCID: PMC13210405 SCOPUS ID: 2-s2.0-105037085733 05/01/2026    
  • Factors Associated With Pre-donation Health-related Quality-of-Life Among Pediatric Sibling Hematopoietic Cell Donors: A DonorKids QL Study. (Switzer GE, Bruce JG, Shaw BE, Kuniyil V, Varni JW, Butler BJ, Erickson C, Mussetter A, Neutzling A, Abdel-Azim H, Aguayo-Hiraldo P, Anderson EJ, Aquino VM, Boone K, Boulad F, Chewning JH, Cooper J, Dahlberg A, Dvorak CC, Galvez-Silva J, Haight AE, Hoag JA, Hudspeth M, Jacobsohn D, Kasow KA, Kitko CL, Krishnamurti L, Madden L, Miller HK, Morales E, Olson TS, Pawlowska AB, Prasad VK, Quigg TC, Scaradavou A, Shah NC, Shenoy S, Terwilliger NB, Wiener L, Yanik GA, Yu LC, Pulsipher MA) Transplant Cell Ther 2026 Jul;32(7):885.e1-885.e14 PMID: 41997298 PMCID: PMC13479314 SCOPUS ID: 2-s2.0-105038259426 04/18/2026    
  • Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant. (Liberio N, Allbee-Johnson M, Ahn KW, Moskop A, Phelan R, Shaw BE, Page KM, Schultz KR, Phillips CL, Mehta PA, Qayed M, Sharma A, Lipsitt AE, Symons H, Bolaños-Meade J, Kharbanda S, Dvorak CC, Kapoor N, Doherty EE, Chavan RS, Broglie L) J Clin Oncol 2026 Apr 10;44(11):1003-1015 PMID: 41740085 PMCID: PMC13162296 SCOPUS ID: 2-s2.0-105034223811 02/25/2026       2 Citations
  • Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial. (Pidala J, Logan B, Lee SJ, Shaw BE, Devine S, Ciurea SO, Horowitz M, He N, Pusic I, Srour SA, Arai S, Juckett M, Uberti J, Hill L, Vasu S, Hogan WJ, Hayes-Lattin B, Westervelt P, Bashey A, Farhadfar N, Grunwald MR, Leifer E, Symons H, Saad A, Vogel J, Erickson C, Buck K, Dehn JG) Transplant Cell Ther 2026 Jun;32(6):678-688 PMID: 41547399 PMCID: PMC13086071 SCOPUS ID: 2-s2.0-105034344999 01/18/2026       2 Citations
  • Visualizing Health Related Quality of Life (HRQoL): understanding comprehension of HRQoL graphs in the allogeneic hematopoietic cell transplant setting. (Cusatis R, Kapfhammer M, Rein L, Szabo A, Reed-Thryselius S, Phelan R, Bingen K, Runaas L, Shaw BE, Flynn KE) J Cancer Surviv 2026 Jan 09 PMID: 41511743 PMCID: PMC13044967 SCOPUS ID: 2-s2.0-105027391304 01/09/2026    
  • Response to "Revisiting Allogeneic Hematopoietic Cell Donor Selection Guidelines: Umbilical Cord Blood in the PTCy Era". (Shaffer BC, Spellman SR, Shaw BE, Jimenez Jimenez AM) Transplant Cell Ther 2026 May;32(5):626.e1-626.e2 PMID: 41490540 SCOPUS ID: 2-s2.0-105035413557 01/06/2026       1 Citation
  • Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial. (Dehn JG, Logan B, Lee SJ, Shaw BE, Devine S, Ciurea SO, Horowitz M, He N, Pusic I, Srour SA, Arai S, Juckett M, Uberti J, Hill L, Vasu S, Hogan WJ, Hayes-Lattin B, Westervelt P, Bashey A, Farhadfar N, Grunwald MR, Leifer E, Symons H, Saad A, Vogel J, Erickson C, Buck K, Pidala J) Transplant Cell Ther 2026 Mar;32(3):346-357 PMID: 41213499 PMCID: PMC12779121 SCOPUS ID: 2-s2.0-105023471554 11/11/2025       6 Citations
  • Acute Toxicities of Bone Marrow Donation in Unrelated Donors with Sickle Cell Trait: A Center for International Blood and Marrow Transplantation Research Analysis. (Farhadfar N, Bo-Subait S, Schmidt G, Logan B, Aljurf M, Badawy S, Beitinjaneh A, Gowda L, Kasow KA, Seftel M, Sharma A, Rangarajan HG, Herr M, Battiwalla M, Shaw BE, Stefanski HE) Transplant Cell Ther 2026 Feb;32(2):217.e1-217.e12 PMID: 41072772 PMCID: PMC13051645 SCOPUS ID: 2-s2.0-105023514233 10/11/2025    
  • Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide. (Modi D, Aljawai YM, DeFor TE, Bupp C, Al Malki MM, Bolaños-Meade J, Gooptu M, Jimenez Jimenez AM, Liu H, Mensah FA, Mielcarek M, Shaffer BC, Shaw BE, Spellman SR, Stefanski HE, Auletta JJ, Devine SM, Khimani F, Abboud R) Blood Adv 2026 Jan 13;10(1):233-245 PMID: 41052403 PMCID: PMC12811456 SCOPUS ID: 2-s2.0-105027139766 10/06/2025       11 Citations
  • Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377. (Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar OS, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, Jurdi NE, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Pérez WS, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M) Transplant Cell Ther 2026 Jun;32(6):764 PMID: 41027557 PMCID: PMC12606686 SCOPUS ID: 2-s2.0-105018107118 10/01/2025       1 Citation
  • Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation. (Lee SJ, Logan B, Horowitz MM, Dehn JG, Pidala J, Grunwald MR, Westervelt P, Farhadfar N, Hogan WJ, Bashey A, Hayes-Lattin B, Hill L, Brunstein C, Arai S, Srour SA, Symons H, Uberti J, Vasu S, Pusic I, Juckett M, Leifer E, He N, Devine S, Shaw BE, Ciurea SO) J Clin Oncol 2025 Nov;43(31):3369-3380 PMID: 40966481 PMCID: PMC12700293 SCOPUS ID: 2-s2.0-105020636771 09/18/2025       18 Citations
  • Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR. (Jimenez Jimenez AM, Spellman SR, Politikos I, McCurdy SR, Devine SM, Malki MMA, Bolon YT, Lee SJ, Dehn J, Pidala J, Maiers M, Askar M, Malmberg C, Auletta JJ, Stefanski H, Broglie L, Qayed M, Horwitz M, Wilder JS, Gooptu M, Mehta RS, Fernandez-Viña M, Shaw BE, Shaffer BC) Transplant Cell Ther 2025 Dec;31(12):973-988 PMID: 40619101 PMCID: PMC12344661 SCOPUS ID: 2-s2.0-105011709083 07/07/2025       41 Citations
  • Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study. (Gupta M, Schoettler ML, Brazauskas R, Bo-Subait S, Orozco G, Battiwalla M, Buchbinder D, Hamilton BK, Savani BN, Schoemans H, Sorror ML, Ahmed S, Badawy SM, Bhushan V, Birdsey K, Couriel D, Doherty EE, Donato M, Farag SS, Gutman J, Horwitz M, El Jurdi N, Maakaron JE, Maziarz RT, Pineiro L, Schiller G, Weisdorf DJ, William BM, Shaw BE, Phelan R, Porter DL, Abt PL, Levine M) Transplantation 2025 Oct 01;109(10):1626-1638 PMID: 40545568 PMCID: PMC12353406 SCOPUS ID: 2-s2.0-105012999093 06/23/2025    
  • Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study. (Gupta M, Schoettler ML, Orozco G, Brazauskas R, Bo-Subait S, Battiwalla M, Buchbinder D, Hamilton BK, Savani BN, Schoemans H, Sorror ML, Ahmed S, Badawy SM, Bhushan V, Birdsey K, Couriel D, Doherty EE, Donato M, Farag SS, Gutman J, Horwitz M, El Jurdi N, Maakaron JE, Maziarz RT, Pineiro L, Schiller G, Weisdorf DJ, William BM, Shaw BE, Phelan R, Porter DL, Levine M, Abt PL) Transplantation 2025 Oct 01;109(10):1611-1625 PMID: 40545567 PMCID: PMC12353109 SCOPUS ID: 2-s2.0-105009062497 06/23/2025       3 Citations
  • Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation. (Al Malki MM, Bo-Subait S, Logan B, Olson J, Kou J, Smith S, Leckrone E, Wu J, Stefanski HE, Auletta JJ, Spellman SR, Malmberg C, Askar M, Cusatis R, Shaffer BC, Modi D, Khimani F, Gooptu M, Hamadani M, Madbouly A, Maiers M, Fingerson S, Cook R, Ballen K, Loren A, Larkin K, Arai S, Qayed M, Choi SW, Broglie L, Shaw BE, Devine SM, Jimenez Jimenez AM) J Clin Oncol 2025 Sep;43(25):2772-2781 PMID: 40523209 PMCID: PMC12353616 SCOPUS ID: 2-s2.0-105008736226 06/16/2025       36 Citations
  • An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy. (Schoettler ML, Gavriilaki E, Carreras E, Bo-Kyoung C, Dandoy CE, Ho VT, Jodele S, Moiseev I, Sánchez-Ortega I, Srivastava A, Atsuta Y, Carpenter PA, Koreth J, Kröger N, Ljungman P, Page K, Popat U, Shaw BE, Sureda AM, Soiffer R, Vasu S) Transplant Cell Ther 2025 Sep;31(9):610-623 PMID: 40514012 PMCID: PMC12718118 SCOPUS ID: 2-s2.0-105011077111 06/14/2025       8 Citations
  • Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR. (Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar O, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, El-Jurdi N, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez W, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M) Transplant Cell Ther 2025 Aug;31(8):505-532 PMID: 40398621 PMCID: PMC12302970 SCOPUS ID: 2-s2.0-105009874373 05/22/2025       111 Citations
  • Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis. (Nath K, Zhang MJ, Bye M, Abid MB, Benjamin C, Betts B, Bhatt NS, Arrieta Bolaños E, Bolon YT, Gadalla SM, Grunwald MR, Krem MM, Lee SJ, Marsh SGE, Martino R, Mehta PA, Milano F, Prestidge T, Saultz JN, Shaw BE, Spellman SR, Choe H, Shaffer BC) Blood Adv 2025 Jul 22;9(14):3469-3478 PMID: 40048743 PMCID: PMC12274812 SCOPUS ID: 2-s2.0-105011487497 03/06/2025       24 Citations
  • Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation. (Shaffer BC, Gooptu M, DeFor T, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez AM, Al Malki MM) J Clin Oncol 2025 Feb;43(4):476-478 PMID: 39504503 PMCID: PMC11779590 SCOPUS ID: 2-s2.0-85209770508 11/06/2024       1 Citation
  • Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial. (Dehn JG, Logan B, Shaw BE, Devine S, Ciurea SO, Horowitz M, He N, Pusic I, Srour SA, Arai S, Juckett M, Uberti J, Hill L, Vasu S, Hogan WJ, Hayes-Lattin B, Westervelt P, Bashey A, Farhadfar N, Grunwald MR, Leifer E, Symons H, Saad A, Vogel J, Erickson C, Buck K, Lee SJ, Pidala J) medRxiv 2024 Sep 16 PMID: 39371123 PMCID: PMC11451755 10/07/2024    
  • Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes. (Spellman SR, Sparapani R, Maiers M, Shaw BE, Laud P, Bupp C, He M, Devine SM, Logan BR) Blood Adv 2024 Dec 10;8(23):6082-6087 PMID: 39368807 PMCID: PMC11652765 SCOPUS ID: 2-s2.0-85212173730 10/06/2024       26 Citations
  • Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors. (Shaffer BC, Gooptu M, DeFor TE, Maiers M, Bolaños-Meade J, Abboud R, Briggs AD, Khimani F, Modi D, Newcomb R, Shpall EJ, Bupp C, Spellman SR, Stefanski HE, Shaw BE, Auletta JJ, Devine SM, Jimenez Jimenez AM, Al Malki MM) J Clin Oncol 2024 Oct;42(28):3277-3286 PMID: 39018507 PMCID: PMC11421565 SCOPUS ID: 2-s2.0-85201047010 07/17/2024       103 Citations
  • Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry. (Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE) Transplant Cell Ther 2024 Sep;30(9):917.e1-917.e12 PMID: 38944153 PMCID: PMC11587342 SCOPUS ID: 2-s2.0-85199289175 06/30/2024       78 Citations
  • Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party. (Schoemans H, Burns LJ, Liptrott SJ, Murray J, Kenyon M, Barata A, Bolaños N, Scholl I, Hamilton B, Phelan R, Buchbinder D, Penack O, Moiseev I, Boreland W, Peczynski C, De Geest S, Sureda A, Snowden JA, Shaw B, Peric Z, Kroeger N) Bone Marrow Transplant 2024 Sep;59(9):1286-1294 PMID: 38890544 PMCID: PMC11371514 SCOPUS ID: 2-s2.0-85196315053 06/19/2024       7 Citations
  • Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes. (Bolon YT, Atshan R, Allbee-Johnson M, Estrada-Merly N, Auletta JJ, Broglie L, Cusatis R, Page KM, Phelan R, Sajulga R Jr, Shaw BE, Spahn A, Steinert P, Stewart V, Vierra-Green C, Lee SJ, Spellman SR) Transplant Cell Ther 2024 Sep;30(9):921.e1-921.e22 PMID: 38871054 PMCID: PMC11809440 SCOPUS ID: 2-s2.0-85198556368 06/14/2024       3 Citations
  • Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry. (Schonfeld SJ, Valcarcel B, Meyer CL, Shaw BE, Phelan R, Rizzo JD, Brunson A, Cooley JJP, Abrahão R, Wun T, Gadalla SM, Engels E, Albert PS, Yusuf R, Spellman SR, Curtis RE, Auletta JJ, Muffly L, Keegan THM, Morton LM) Blood Adv 2024 Aug 13;8(15):4102-4112 PMID: 38865710 PMCID: PMC11342185 SCOPUS ID: 2-s2.0-85201458048 06/12/2024       1 Citation
  • Optimal Donor Selection Across Multiple Outcomes For Hematopoietic Stem Cell Transplantation By Bayesian Nonparametric Machine Learning. (Sparapani RA, Maiers M, Spellman SR, Shaw BE, Laud PW, Devine SM, Logan BR) medRxiv 2024 May 09 PMID: 38766030 PMCID: PMC11100939 05/20/2024    
  • Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastim. (Stefanski HE, Kuxhausen M, Bo-Subait S, Kobusingye H, Mattila D, Schenfeld J, Sandschafer D, De Oliveira Brandao C, Burns LJ, Shaw BE, Pulsipher MA, Miller JP, Devine SM) Blood Adv 2024 Aug 13;8(15):4196-4206 PMID: 38687368 PMCID: PMC11372396 SCOPUS ID: 2-s2.0-85201668483 04/30/2024       10 Citations
  • Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients. (Shaw BE, Flynn KE, He N, Cusatis R, D'Souza A, Hamilton BK, Horowitz MM, Mattila D, Phelan R, Lee SJ, Brazauskas R) Cancer 2024 May 15;130(10):1826-1835 PMID: 38198511 PMCID: PMC11058023 SCOPUS ID: 2-s2.0-85181878144 01/10/2024       4 Citations
  • Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. (Chhabra S, Jerkins JH, Monahan K, Szabo A, Shah NN, Abedin S, Runaas L, Fenske TS, Pasquini MC, Shaw BE, Drobyski WR, Saber W, D'Souza A, Dhakal B, Mohan M, Longo W, Hamadani M) Bone Marrow Transplant 2024 Mar;59(3):373-379 PMID: 38177221 SCOPUS ID: 2-s2.0-85181508004 01/05/2024       8 Citations
  • Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018. (Valcarcel B, Schonfeld SJ, Meyer CL, Brunson A, Cooley JJP, Abrahão R, Wun T, Auletta JJ, Gadalla SM, Engels E, Albert PS, Spellman SR, Rizzo JD, Shaw BE, Muffly L, Keegan THM, Morton LM) Transplant Cell Ther 2024 Feb;30(2):239.e1-239.e11 PMID: 37981238 PMCID: PMC10872486 SCOPUS ID: 2-s2.0-85180597524 11/20/2023       1 Citation
  • Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis. (Taylor MR, Cole SW, Strom J, Brazauskas R, Baker KS, Phelan R, Buchbinder D, Hamilton B, Schoemans H, Shaw BE, Sharma A, Bhatt NS, Badawy SM, Winestone LE, Preussler JM, Mayo S, Jamani K, Nishihori T, Lee MA, Knight JM) Blood Adv 2023 Nov 28;7(22):6830-6838 PMID: 37773924 PMCID: PMC10679811 SCOPUS ID: 2-s2.0-85178332888 09/29/2023       12 Citations
  • Prevalence of Sleep Aid Medication Use in Patients Receiving a Hematopoietic Cell Transplant on an Inpatient Unit. (Cusatis R, Ibrahim A, Knight JM, D'Souza A, Shaw BE) Hematol Oncol Stem Cell Ther 2023 May 23;16(4):366-369 PMID: 37363976 PMCID: PMC11792084 SCOPUS ID: 2-s2.0-85163346266 06/26/2023       1 Citation
  • Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic. (Devine SM, Bo-Subait S, Kuxhausen M, Spellman SR, Bupp C, Ahn KW, Stefanski HE, Auletta JJ, Logan BR, Shaw BE) Blood Adv 2023 Oct 10;7(19):5982-5993 PMID: 37036959 PMCID: PMC10580174 SCOPUS ID: 2-s2.0-85172442056 04/11/2023       25 Citations
  • Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. (Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez WS, Phelan R, Riches ML, Rizzo JD, Saber W, Spellman SR, Stefanski HE, Steinert P, Tuschl E, Yusuf R, Zhang MJ, Shaw BE) Transplant Cell Ther 2023 Jun;29(6):346.e1-346.e10 PMID: 36924931 PMCID: PMC10239334 SCOPUS ID: 2-s2.0-85153327578 03/17/2023       76 Citations
  • Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T. (Akinola IM, Cusatis R, Pasquini MC, Shaw BE, Bollu V, Dalal A, Tesfaye M, Flynn KE) Transplant Cell Ther 2023 Apr;29(4):254.e1-254.e9 PMID: 36634738 PMCID: PMC10369368 SCOPUS ID: 2-s2.0-85147859869 01/13/2023       21 Citations
  • Unrelated Stem Cell Donor HLA Match Likelihood in the US Registry Incorporating HLA-DPB1 Permissive Mismatching. (Gragert L, Spellman SR, Shaw BE, Maiers M) Transplant Cell Ther 2023 Apr;29(4):244-252 PMID: 36623771 PMCID: PMC10040431 SCOPUS ID: 2-s2.0-85147563685 01/10/2023       26 Citations
  • Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia. (Guru Murthy GS, Logan BR, Bo-Subait S, Beitinjaneh A, Devine S, Farhadfar N, Gowda L, Hashmi S, Lazarus H, Nathan S, Sharma A, Yared JA, Stefanski HE, Pulsipher MA, Hsu JW, Switzer GE, Panch SR, Shaw BE) Am J Hematol 2023 Apr;98(4):608-619 PMID: 36606713 PMCID: PMC10290878 SCOPUS ID: 2-s2.0-85146394154 01/07/2023       25 Citations
  • Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial. (Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J) Transplant Cell Ther 2023 Mar;29(3):208.e1-208.e6 PMID: 36584941 PMCID: PMC9992261 SCOPUS ID: 2-s2.0-85146784394 12/31/2022       57 Citations
  • Relationship between work performance and quality of life in long-term survivors of pediatric and adolescent hematopoietic cell transplant. (Bhatt NS, Brazauskas R, Torres AP, Phelan R, Shaw BE) J Cancer Surviv 2024 Jun;18(3):772-780 PMID: 36585573 PMCID: PMC9803401 SCOPUS ID: 2-s2.0-85145237193 12/31/2022       1 Citation
  • Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research. (Schoettler ML, Carreras E, Cho B, Dandoy CE, Ho VT, Jodele S, Moissev I, Sanchez-Ortega I, Srivastava A, Atsuta Y, Carpenter P, Koreth J, Kroger N, Ljungman P, Page K, Popat U, Shaw BE, Sureda A, Soiffer R, Vasu S) Transplant Cell Ther 2023 Mar;29(3):151-163 PMID: 36442770 PMCID: PMC10119629 SCOPUS ID: 2-s2.0-85147211751 11/29/2022       139 Citations
  • Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors. (Hong S, Zhao J, Wang S, Wang H, Lee JH, Farhadfar N, McGuirk JP, Savani BN, Shahrukh HK, Stiff P, Khera N, Hahn T, Loren AW, Jaglowski SM, Wood WA, Saber W, Cerny J, Holtan SG, Reynolds JM, Deol A, Jim H, Uberti J, Whalen V, Yi JC, Preussler J, Baker KS, Shaw BE, Devine S, Syrjala K, Majhail NS, Wingard JR, Al-Mansour Z) Transplant Cell Ther 2023 Mar;29(3):202.e1-202.e8 PMID: 36427784 PMCID: PMC10165614 SCOPUS ID: 2-s2.0-85146977106 11/26/2022       4 Citations
  • Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102. (Cusatis R, Martens MJ, Nakamura R, Cutler CS, Saber W, Lee SJ, Logan BR, Shaw BE, Gregory A, D'Souza A, Hamilton BK, Horowitz MM, Flynn KE) Am J Hematol 2023 Feb;98(2):229-250 PMID: 36251401 PMCID: PMC9839494 SCOPUS ID: 2-s2.0-85142150726 10/18/2022       19 Citations
  • Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Transplant Cell Ther 2022 Oct;28(10):717 PMID: 36202527 SCOPUS ID: 2-s2.0-85101258094 10/07/2022    
  • Corrigendum to 'Current Use and Trends in Hematopoietic Cell Transplantation in the United States' [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplant Cell Ther 2022 Oct;28(10):715-716 PMID: 36202526 SCOPUS ID: 2-s2.0-85108559179 10/07/2022       2 Citations
  • Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review. (Cusatis R, Balza J, Uttke Z, Kode V, Suelzer E, Shaw BE, Flynn KE) Qual Life Res 2023 Apr;32(4):939-964 PMID: 36203005 PMCID: PMC10259487 SCOPUS ID: 2-s2.0-85139480842 10/07/2022       6 Citations
  • Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885, (S1083879120304146), (10.1016/j.bbmt.2020.07.005)] (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Transplantation and Cellular Therapy October 2022;28(10):717 SCOPUS ID: 2-s2.0-85101258094 10/01/2022    
  • Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182, (S1083879120302251), (10.1016/j.bbmt.2020.04.013)] (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Transplantation and Cellular Therapy October 2022;28(10):715-716 SCOPUS ID: 2-s2.0-85108559179 10/01/2022       2 Citations
  • CT-524 Orca-T, A Precision Engineered Allograft, Results in High GVHD-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies (Meyer E, Pavlova A, Gandhi A, Hoeg R, Oliai C, Mehta R, Srour S, McGuirk J, Waller E, Fernhoff N, Killian MS, Mcclellan J, Putnam A, Shaw B, Abedi M, Negrin R) Clinical Lymphoma Myeloma and Leukemia October 2022;22:S447 SCOPUS ID: 2-s2.0-85138209413 10/01/2022       3 Citations
  • Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues (Worel N, Aljurf M, Anthias C, Buser AS, Cody M, Fechter M, Galeano S, Greinix HT, Kisch AM, Koh MBC, Mengling T, Nicoloso G, Niederwieser D, Pulsipher MA, Seber A, Shaw BE, Stefanski HE, Switzer GE, Szer J, van Walraven SM, Yang H, Halter JP) Lancet Haematology August 2022;9(8):e605-e614 SCOPUS ID: 2-s2.0-85134830083 08/01/2022       32 Citations
  • Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues. (Worel N, Aljurf M, Anthias C, Buser AS, Cody M, Fechter M, Galeano S, Greinix HT, Kisch AM, Koh MBC, Mengling T, Nicoloso G, Niederwieser D, Pulsipher MA, Seber A, Shaw BE, Stefanski HE, Switzer GE, Szer J, van Walraven SM, Yang H, Halter JP) Lancet Haematol 2022 Aug;9(8):e605-e614 PMID: 35901845 SCOPUS ID: 2-s2.0-85134830083 07/29/2022       32 Citations
  • Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study. (Krishnamurti L, Arnold SD, Haight A, Abraham A, Guilcher GM, John T, Bakshi N, Shenoy S, Syrjala K, Martin PL, Chaudhury S, Eames G, Olowoselu OF, Hsieh M, De La Fuente J, Kasow KA, Stenger E, Mertens A, El-Rassi F, Lane P, Shaw BE, Meacham L, Archer D) JMIR Res Protoc 2022 Jul 06;11(7):e36780 PMID: 35793124 PMCID: PMC9301564 SCOPUS ID: 2-s2.0-85134482839 07/07/2022       9 Citations
  • The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials. (Farhadfar N, Ahn KW, Bo-Subait S, Logan B, Stefanski HE, Hsu JW, Panch S, Confer D, Liu H, Badawy SM, Beitinjaneh A, Diaz MA, Hildebrandt GC, Kelkar AH, Lazarus HM, Murthy HS, Preussler JM, Schears RM, Sharma A, van der Poel M, Bruce JG, Pulsipher MA, Shaw BE, Wingard JR, Switzer GE) Transplant Cell Ther 2022 Sep;28(9):603.e1-603.e7 PMID: 35688325 PMCID: PMC9427696 SCOPUS ID: 2-s2.0-85134804662 06/11/2022       9 Citations
  • Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. (Phelan R, Chen M, Bupp C, Bolon YT, Broglie L, Brunner-Grady J, Burns LJ, Chhabra S, Christianson D, Cusatis R, Devine SM, D'Souza A, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini M, Pérez WS, Riches M, Rizzo D, Saber W, Spellman SR, Stefanski HE, Steinert P, Weisdorf D, Horowitz M, Auletta JJ, Shaw BE, Arora M) Transplant Cell Ther 2022 Jul;28(7):409.e1-409.e10 PMID: 35447374 PMCID: PMC9840526 SCOPUS ID: 2-s2.0-85130441260 04/22/2022       84 Citations
  • Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-Report from World Marrow Donor Association. (Jöris MM, Schmidt AH, Bernas SN, Feinberg J, Sacchi N, Elmoazzen H, Fournier D, Oguz F, Oliveira D, Yang KL, Mousavi SA, Moomivand S, Abecasis M, Villa J, Fechter MM, Seval GC, Jeyarajah T, Devine SM, Shaw BE, Galarza P, Malan R, Harvey C, Forman SJ, Foeken L) Bone Marrow Transplant 2022 Jun;57(6):1021-1024 PMID: 35397653 PMCID: PMC8994088 SCOPUS ID: 2-s2.0-85127635726 04/11/2022       14 Citations
  • Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. (Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Mattila D, Mussetter A, Bruzauskas R, Chen M, Leckrone E, Myers J, Mau LW, Rizzo JD, Saber W, Horowitz M, Lee SJ, Burns LJ, Shaw B) Transplant Cell Ther 2022 Feb;28(2):112.e1-112.e9 PMID: 34757219 PMCID: PMC8915447 SCOPUS ID: 2-s2.0-85121127060 11/11/2021       11 Citations
  • HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide. (Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MM, Modi D, Grunwald MR, Nishihori T, Kuxhausen M, Fingerson S, McKallor C, Bashey A, Kasamon YL, Bolon YT, Saad A, McGuirk J, Paczesny S, Gadalla SM, Marsh SGE, Shaw BE, Spellman SR, Lee SJ, Petersdorf EW) Blood 2022 Mar 10;139(10):1452-1468 PMID: 34724567 PMCID: PMC8914182 SCOPUS ID: 2-s2.0-85124046605 11/02/2021       110 Citations
  • Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation. (Hough R, Lopes A, Patrick P, Russell N, Raj K, Tholouli E, A Snowden J, Collin M, El-Mehidi N, Lawrie A, Clifton-Hadley L, Veys P, Craddock C, Mackinnon S, Cook G, Shaw B, Marks D) Blood Adv 2022 Apr 12;6(7):2414-2426 PMID: 34700343 PMCID: PMC9006284 SCOPUS ID: 2-s2.0-85129231043 10/27/2021       2 Citations
  • Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year. (Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM) Transplant Cell Ther 2021 Nov;27(11):885-907 PMID: 34461278 PMCID: PMC8556300 SCOPUS ID: 2-s2.0-85116810681 08/31/2021       19 Citations
  • Biobehavioral Research and Hematopoietic Stem Cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy. (Kelly DL, Syrjala K, Taylor M, Rentscher KE, Hashmi S, Wood WA, Jim H, Barata A, Flynn KE, Burns LJ, Shaw BE, Petersdorf E, Yero AC, Emmrich AD, Morris KE, Costanzo ES, Knight JM) Transplant Cell Ther 2021 Sep;27(9):747-757 PMID: 34139388 PMCID: PMC8428782 SCOPUS ID: 2-s2.0-85110419978 06/18/2021       22 Citations
  • Optimal Donor Selection for Hematopoietic Cell Transplantation Using Bayesian Machine Learning. (Logan BR, Maiers MJ, Sparapani RA, Laud PW, Spellman SR, McCulloch RE, Shaw BE) JCO Clin Cancer Inform 2021 May;5:494-507 PMID: 33950708 PMCID: PMC8443829 SCOPUS ID: 2-s2.0-85105478562 05/06/2021       43 Citations
  • National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. (Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J) J Clin Oncol 2021 Jun 20;39(18):1971-1982 PMID: 33905264 PMCID: PMC8260905 SCOPUS ID: 2-s2.0-85108386444 04/28/2021       198 Citations
  • Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States. (Bhatt NS, Brazauskas R, Salit RB, Syrjala K, Bo-Subait S, Tecca H, Badawy SM, Baker KS, Beitinjaneh A, Bejanyan N, Byrne M, Dias A, Farhadfar N, Freytes CO, Ganguly S, Hashmi S, Hayashi RJ, Hong S, Inamoto Y, Jamani K, Kasow KA, Khera N, Krem MM, Lazarus HM, Lee CJ, Lee S, Majhail NS, Malone AK, Marks DI, Mau LW, Mayo SJ, Muffly LS, Nathan S, Nishihori T, Page KM, Preussler J, Rangarajan HG, Rotz SJ, Salooja N, Savani BN, Schears R, Schechter-Finkelstein T, Schiller G, Shah AJ, Sharma A, Wang T, Wirk B, Battiwalla M, Schoemans H, Hamilton B, Buchbinder D, Phelan R, Shaw B) Transplant Cell Ther 2021 Aug;27(8):679.e1-679.e8 PMID: 33895402 PMCID: PMC8425287 SCOPUS ID: 2-s2.0-85107434203 04/26/2021       21 Citations
  • The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic. (Hsu JW, Farhadfar N, Murthy H, Logan BR, Bo-Subait S, Frey N, Goldstein SC, Horowitz MM, Lazarus H, Schwanke JD, Shah NN, Spellman SR, Switzer GE, Devine SM, Shaw BE, Wingard JR) Transplant Cell Ther 2021 Jun;27(6):507-516 PMID: 33865804 PMCID: PMC8217124 SCOPUS ID: 2-s2.0-85108052714 04/19/2021       39 Citations
  • Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study. (Seftel MD, Chitphakdithai P, Miller JP, Kobusingye H, Logan BR, Linenberger M, Artz AS, Haight AE, Jacobsohn DA, Litzow MR, Magalhaes-Silverman M, Selby GB, Vusirikala M, Horowitz MM, Switzer GE, Confer DL, Shaw BE, Pulsipher MA) Transplant Cell Ther 2021 Apr;27(4):352.e1-352.e5 PMID: 33836890 PMCID: PMC8036235 SCOPUS ID: 2-s2.0-85101149566 04/11/2021       4 Citations
  • Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation. (Mayor NP, Wang T, Lee SJ, Kuxhausen M, Vierra-Green C, Barker DJ, Auletta J, Bhatt VR, Gadalla SM, Gragert L, Inamoto Y, Morris GP, Paczesny S, Reshef R, Ringdén O, Shaw BE, Shaw P, Spellman SR, Marsh SGE) J Clin Oncol 2021 Jul 20;39(21):2397-2409 PMID: 33835855 PMCID: PMC8280068 SCOPUS ID: 2-s2.0-85112125420 04/10/2021       44 Citations
  • Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations. (Panch SR, Logan B, Sees JA, Bo-Subait S, Savani B, Shah NN, Hsu JW, Switzer G, Lazarus HM, Anderlini P, Hematti P, Confer D, Pulsipher MA, Shaw BE, Stroncek DF) Transplant Cell Ther 2021 Jun;27(6):503.e1-503.e8 PMID: 33823169 PMCID: PMC8217152 SCOPUS ID: 2-s2.0-85103924669 04/07/2021       2 Citations
  • Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study (Seftel MD, Chitphakdithai P, Miller JP, Kobusingye H, Logan BR, Linenberger M, Artz AS, Haight AE, Jacobsohn DA, Litzow MR, Magalhaes-Silverman M, Selby GB, Vusirikala M, Horowitz MM, Switzer GE, Confer DL, Shaw BE, Pulsipher MA) Transplantation and Cellular Therapy April 2021;27(4):352-352.e5 SCOPUS ID: 2-s2.0-85101149566 04/01/2021       4 Citations
  • Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation. (Worel N, Shaw BE, Aljurf M, Koh M, Seber A, Weisdorf D, Schwartz J, Galeano S, Kodera Y, Eldridge PW, Hashmi S, Atsuta Y, Szer J, Saber W, Niederwieser D, Greinix HT, Worldwide Network for Blood & Marrow Transplantation) Transplant Cell Ther 2021 Mar;27(3):270.e1-270.e6 PMID: 33781537 PMCID: PMC7834678 SCOPUS ID: 2-s2.0-85101114408 03/31/2021       21 Citations
  • Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation (Worel N, Shaw BE, Aljurf M, Koh M, Seber A, Weisdorf D, Schwartz J, Galeano S, Kodera Y, Eldridge PW, Hashmi S, Atsuta Y, Szer J, Saber W, Niederwieser D, Greinix HT) Transplantation and Cellular Therapy March 2021;27(3):270-270.e6 SCOPUS ID: 2-s2.0-85101114408 03/01/2021       21 Citations
  • Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program (El Fakih R, Greinix H, Koh M, Shaw B, Mohty M, Al Nahedh M, Saber W, Kharfan-Dabaja MA, Perales MA, Savani BN, Majhail NS, Passweg JR, Sureda A, Ahmed SO, Gluckman E, Riches M, El-Jawahri A, Rondelli D, Srivastava A, Faulkner L, Atsuta Y, Ballen KK, Rasheed W, Okamoto S, Seber A, Chao N, Kröger N, Kodera Y, Szer J, Hashmi SK, Horowitz MM, Weisdorf D, Niederwieser D, Aljurf M) Transplantation and Cellular Therapy March 2021;27(3):267-267.e5 SCOPUS ID: 2-s2.0-85101137848 03/01/2021       9 Citations
  • Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. (Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, Dandoy C, Gauthier J, Gowda L, Perales MA, Seropian S, Shaw BE, Tuschl EE, Zeidan AM, Riches ML, Shah GL) Lancet Haematol 2021 Mar;8(3):e185-e193 PMID: 33482113 PMCID: PMC7816949 SCOPUS ID: 2-s2.0-85100738660 01/23/2021       317 Citations
  • Second primary malignancies (Manning A, Shaw BE) Blood and Marrow Transplant Handbook Comprehensive Guide for Patient Care 13 January 2021:701-710 SCOPUS ID: 2-s2.0-105010288375 01/13/2021    
  • International Blood and Marrow Registries: trends on long-term data collection (Phelan R, Passweg JR, Baldomero H, Iida M, Atsuta Y, Okamoto S, Aljurf M, Alfraih F, Shaw BE) Blood and Marrow Transplantation Long Term Management Survivorship After Transplant Second Edition 1 January 2021:6-13 SCOPUS ID: 2-s2.0-85152309078 01/01/2021       1 Citation
  • Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States. (Hong S, Brazauskas R, Hebert KM, Ganguly S, Abdel-Azim H, Diaz MA, Beattie S, Ciurea SO, Szwajcer D, Badawy SM, Gratwohl AA, LeMaistre C, Aljurf MDSM, Olsson RF, Bhatt NS, Farhadfar N, Yared JA, Yoshimi A, Seo S, Gergis U, Beitinjaneh AM, Sharma A, Lazarus H, Law J, Ulrickson M, Hashem H, Schoemans H, Cerny J, Rizzieri D, Savani BN, Kamble RT, Shaw BE, Khera N, Wood WA, Hashmi S, Hahn T, Lee SJ, Rizzo JD, Majhail NS, Saber W) Cancer 2021 Feb 15;127(4):609-618 PMID: 33085090 PMCID: PMC7855526 SCOPUS ID: 2-s2.0-85092920705 10/22/2020       19 Citations
  • Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023. (Farhadfar N, Burns LJ, Mupfudze T, Shaw BE, Bollard CM, Devine SM, Horowitz MM, Jones RJ, Murthy HS, Wingard JR, Lee SJ) Transplant Cell Ther 2021 Feb;27(2):183.e1-183.e7 PMID: 33045387 PMCID: PMC7546661 SCOPUS ID: 2-s2.0-85096828571 10/13/2020       8 Citations
  • Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis. (Dehn J, Chitphakdithai P, Shaw BE, McDonald AA, Devine SM, Burns LJ, Spellman S) Transplant Cell Ther 2021 Feb;27(2):184.e1-184.e13 PMID: 33045385 PMCID: PMC8015680 SCOPUS ID: 2-s2.0-85095990503 10/13/2020       34 Citations
  • Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study. (Switzer GE, Bruce JG, Kiefer DM, Kobusingye H, Abebe KZ, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA) Biol Blood Marrow Transplant 2020 Dec;26(12):2365-2371 PMID: 32829080 PMCID: PMC7686016 SCOPUS ID: 2-s2.0-85091208680 08/24/2020       9 Citations
  • Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. (Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, Wood WA, Brazauskas R, Lehmann L, Pasquini MC, Seber A, Lu PH, Atsuta Y, Riches M, Perales MA, Worel N, Okamoto S, Srivastava A, Chemaly RF, Cordonnier C, Dandoy CE, Wingard JR, Kharfan-Dabaja MA, Hamadani M, Majhail NS, Waghmare AA, Chao N, Kröger N, Shaw B, Mohty M, Niederwieser D, Greinix H, Hashmi SK, WBMT and the CIBMTR Health Services and International Studies Committee) Biol Blood Marrow Transplant 2020 Dec;26(12):2181-2189 PMID: 32717432 PMCID: PMC7380217 SCOPUS ID: 2-s2.0-85089451061 07/28/2020       55 Citations
  • Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2020 Oct;26(10):1876-1885 PMID: 32653622 PMCID: PMC7571859 SCOPUS ID: 2-s2.0-85089134303 07/13/2020       8 Citations
  • Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score. (Berro M, Chhabra S, Piñana JL, Arbelbide J, Rivas MM, Basquiera AL, Vitriu A, Requejo A, Milovic V, Yantorno S, Bentolila G, Garcia JJ, Castro M, Palmer S, Saslavsky M, Duarte P, Cerutti A, Jarchum G, Tisi Baña M, Thapa B, Solano C, Sureda A, Rovira M, Shaw BE, Kusminsky G, Grupo Argentino de Trasplante de Médula Ósea y Terapia Celular (GATMO-TC)) Biol Blood Marrow Transplant 2020 Oct;26(10):1828-1832 PMID: 32640312 SCOPUS ID: 2-s2.0-85088997993 07/09/2020       10 Citations
  • Letter to the Editor Regarding "Diagnostic Considerations for COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplantation". (Chhabra S, Abedin S, Graham MB, Ferrer Marrero TM, Hari PN, Shaw BE) Biol Blood Marrow Transplant 2020 Sep;26(9):e241-e242 PMID: 32589922 PMCID: PMC7309826 SCOPUS ID: 2-s2.0-85087728830 06/27/2020       1 Citation
  • Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. (Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR) Bone Marrow Transplant 2021 Feb;56(2):522 PMID: 32514157 PMCID: PMC7722110 SCOPUS ID: 2-s2.0-85086026026 06/10/2020    
  • Absence of damaging effects of stem cell donation in unrelated donors assessed by FISH and gene variance screening. (Nacheva E, Ahyee T, Addada J, Navarette C, Pamphilon D, Regan F, Pawson R, Szydlo R, Goldman J, Mackinnon S, Shaw BE, Madrigal A) Bone Marrow Transplant 2020 Jul;55(7):1290-1296 PMID: 32440014 SCOPUS ID: 2-s2.0-85085313993 05/23/2020       3 Citations
  • Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. (D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Aug;26(8):e177-e182 PMID: 32438042 PMCID: PMC7404814 SCOPUS ID: 2-s2.0-85085969206 05/22/2020       497 Citations
  • Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. (Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Williams KM, Page KM, Vrooman LM, Norkin M, Byrne M, Diaz MA, Kamani N, Bhatt NS, Rezvani A, Farhadfar N, Mehta PA, Hematti P, Shaw PJ, Kamble RT, Schears R, Olsson RF, Hayashi RJ, Gale RP, Mayo SJ, Chhabra S, Rotz SJ, Badawy SM, Ganguly S, Pavletic S, Nishihori T, Prestidge T, Agrawal V, Hogan WJ, Inamoto Y, Shaw BE, Satwani P) Blood Adv 2020 May 12;4(9):2084-2094 PMID: 32396620 PMCID: PMC7218429 SCOPUS ID: 2-s2.0-85086114432 05/13/2020       32 Citations
  • Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia. (Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):e161-e166 PMID: 32389803 PMCID: PMC7206419 SCOPUS ID: 2-s2.0-85084668943 05/12/2020       47 Citations
  • Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplantation Survivors: An Initial Survey. (Salit RB, Lee SJ, Burns LJ, Shaw BE, Majhail NS, Bhatt NS, Wood WA, Syrjala KL) Biol Blood Marrow Transplant 2020 Aug;26(8):1520-1526 PMID: 32360563 PMCID: PMC7546432 SCOPUS ID: 2-s2.0-85086437567 05/04/2020       10 Citations
  • Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. (Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR) Bone Marrow Transplant 2020 Nov;55(11):2121-2131 PMID: 32355289 PMCID: PMC7606543 SCOPUS ID: 2-s2.0-85085105399 05/02/2020       14 Citations
  • Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis. (Hamadani M, Zhang MJ, Tang XY, Fei M, Brunstein C, Chhabra S, D'Souza A, Milano F, Phelan R, Saber W, Shaw BE, Weisdorf D, Devine SM, Horowitz MM) Biol Blood Marrow Transplant 2020 Jul;26(7):1312-1317 PMID: 32283185 PMCID: PMC7194895 SCOPUS ID: 2-s2.0-85083795044 04/14/2020       58 Citations
  • Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML. (Bultitude WP, Schellekens J, Szydlo RM, Anthias C, Cooley SA, Miller JS, Weisdorf DJ, Shaw BE, Roberts CH, Garcia-Sepulveda CA, Lee J, Pearce RM, Wilson MC, Potter MN, Byrne JL, Russell NH, MacKinnon S, Bloor AJ, Patel A, McQuaker IG, Malladi R, Tholouli E, Orchard K, Potter VT, Madrigal JA, Mayor NP, Marsh SGE) Bone Marrow Transplant 2020 Oct;55(10):1975-1984 PMID: 32203258 PMCID: PMC8852820 SCOPUS ID: 2-s2.0-85082190212 03/24/2020       14 Citations
  • Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia. (Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rovó A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly LS) Blood Adv 2020 Mar 24;4(6):983-992 PMID: 32168378 PMCID: PMC7094022 SCOPUS ID: 2-s2.0-85082533373 03/14/2020       51 Citations
  • Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes. (Cusatis RN, Tecca HR, D'Souza A, Shaw BE, Flynn KE) Cancer 2020 Jun 01;126(11):2679-2686 PMID: 32154926 PMCID: PMC7220834 SCOPUS ID: 2-s2.0-85081236553 03/11/2020       17 Citations
  • Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management. (Seftel MD, Kuxhausen M, Burns L, Chitphakdithai P, Confer D, Kiefer D, Lee S, Logan B, O'Donnell P, Pulsipher M, Shah NN, Switzer G, Shaw BE) Biol Blood Marrow Transplant 2020 Jun;26(6):e142-e144 PMID: 32147534 PMCID: PMC7440392 SCOPUS ID: 2-s2.0-85085163476 03/10/2020       9 Citations
  • Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield. (Farhadfar N, Hsu JW, Logan BR, Sees JA, Chitphakdithai P, Sugrue MW, Abdel-Azim H, Anderlini PN, Bredeson C, Chhabra S, Diaz MA, Ganguly S, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Lynch DK, Murthy HS, Olsson RF, Papari M, Przepiorka D, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Yared JA, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR) Blood Adv 2020 Feb 25;4(4):706-716 PMID: 32092138 PMCID: PMC7042992 SCOPUS ID: 2-s2.0-85082202343 02/25/2020       20 Citations
  • Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors. (Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredeson C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugrue M, Warkentin P, Wingard JR) Biol Blood Marrow Transplant 2020 Jun;26(6):1210-1217 PMID: 32088366 PMCID: PMC7347029 SCOPUS ID: 2-s2.0-85082823451 02/24/2020       9 Citations
  • Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes. (Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Pasquini MC, Rizzo RD, Saber W, Shah NN, Shaw BE, Hamadani M, Hari PN) Biol Blood Marrow Transplant 2020 May;26(5):893-901 PMID: 31982543 SCOPUS ID: 2-s2.0-85080146585 01/27/2020       19 Citations
  • Engraftment of rare, pathogenic donor hematopoietic mutations in unrelated hematopoietic stem cell transplantation. (Wong WH, Bhatt S, Trinkaus K, Pusic I, Elliott K, Mahajan N, Wan F, Switzer GE, Confer DL, DiPersio J, Pulsipher MA, Shah NN, Sees J, Bystry A, Blundell JR, Shaw BE, Druley TE) Sci Transl Med 2020 Jan 15;12(526) PMID: 31941826 PMCID: PMC7521140 SCOPUS ID: 2-s2.0-85077940948 01/17/2020       44 Citations
  • Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research. (Buchbinder D, Brazauskas R, Bo-Subait K, Ballen K, Parsons S, John T, Hahn T, Sharma A, Steinberg A, D'Souza A, Kumar AJ, Yoshimi A, Wirk B, Shaw B, Freytes C, LeMaistre C, Bredeson C, Dandoy C, Almaguer D, Marks DI, Szwajcer D, Hale G, Schouten H, Hashem H, Schoemans H, Murthy HS, Lazarus HM, Cerny J, Tay J, Yared JA, Adekola K, Schultz KR, Lehmann L, Burns L, Aljurf M, Diaz MA, Majhail N, Farhadfar N, Kamble R, Olsson R, Schears R, Seo S, Beattie S, Chhabra S, Savani BN, Badawy S, Ganguly S, Ciurea S, Marino S, Gergis U, Kuwatsuka Y, Inamoto Y, Khera N, Hashmi S, Wood W, Saber W) Biol Blood Marrow Transplant 2020 Mar;26(3):553-561 PMID: 31726205 PMCID: PMC7367505 SCOPUS ID: 2-s2.0-85076525725 11/15/2019       19 Citations
  • Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation. (Herr MM, Curtis RE, Tucker MA, Tecca HR, Engels EA, Cahoon EK, Battiwalla M, Buchbinder D, Flowers ME, Brazauskas R, Shaw BE, Morton LM) J Am Acad Dermatol 2020 Sep;83(3):762-772 PMID: 31654664 PMCID: PMC7206613 SCOPUS ID: 2-s2.0-85081343594 10/28/2019       14 Citations
  • Role of Race/Ethnicity in Donor Decisions about Unrelated Hematopoietic Progenitor Cell Donation: Exploring Reasons for Higher Attrition among Racial/Ethnic Minorities. (Anthias C, Shaw BE, Bruce JG, Confer DL, Abress LK, Dew MA, Billen A, O'Leary A, Braund H, Switzer GE) Biol Blood Marrow Transplant 2020 Mar;26(3):593-599 PMID: 31654786 SCOPUS ID: 2-s2.0-85076530462 10/28/2019       41 Citations
  • Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy. (Ruark J, Mullane E, Cleary N, Cordeiro A, Bezerra ED, Wu V, Voutsinas J, Shaw BE, Flynn KE, Lee SJ, Turtle CJ, Maloney DG, Fann JR, Bar M) Biol Blood Marrow Transplant 2020 Jan;26(1):34-43 PMID: 31605820 PMCID: PMC6951812 SCOPUS ID: 2-s2.0-85075482768 10/13/2019       165 Citations
  • Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program. (Pidala J, Mupfudze TG, Payton T, Barker J, Perales MA, Shaw BE, Fernández-Viña M, Burns LJ, Dehn J) Biol Blood Marrow Transplant 2019 Dec;25(12):2501-2506 PMID: 31419569 PMCID: PMC7307219 SCOPUS ID: 2-s2.0-85071839915 08/17/2019       13 Citations
  • Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis. (Badar T, Khan MA, Szabo A, Drobyski W, Chhabra S, Dhakal B, Fenske TS, Hamadani M, Hari P, Jerkins JH, Shah NN, Shaw BE, D'Souza A) Amyloid 2019 Dec;26(4):210-215 PMID: 31347424 SCOPUS ID: 2-s2.0-85074118154 07/28/2019       3 Citations
  • Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. (Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ, Confer DL, Eapen M, Fernandez-Vina M, Hartzman R, Maiers M, Marino SR, Mueller C, Perales MA, Rajalingam R, Pidala J) Blood 2019 Sep 19;134(12):924-934 PMID: 31292117 PMCID: PMC6753623 SCOPUS ID: 2-s2.0-85070717555 07/12/2019       307 Citations
  • A reply to Hurley et al. regarding Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study. (Mayor NP, Hayhurst JD, Turner TR, Szydlo RM, Shaw BE, Bultitude WP, Sayno JR, Tavarozzi F, Latham K, Anthias C, Robinson J, Braund H, Danby R, Perry J, Wilson MC, Bloor AJ, McQuaker IG, MacKinnon S, Marks DI, Pagliuca A, Potter MN, Potter VT, Russell NH, Thomson KJ, Madrigal JA, Marsh SGE) Biol Blood Marrow Transplant 2019 Aug;25(8):e270-e271 PMID: 31195138 SCOPUS ID: 2-s2.0-85070712990 06/14/2019       4 Citations
  • 4-Locus high-resolution HLA allele and haplotype frequencies in Amerindians from Costa Rica. (Arrieta-Bolaños E, Madrigal-Sánchez JJ, Stein JE, Salazar-Sánchez L, Madrigal JA, Marsh SGE, Shaw BE) Hum Immunol 2019 Jul;80(7):409-410 PMID: 31128907 SCOPUS ID: 2-s2.0-85065858602 05/28/2019    
  • 5-Locus high-resolution HLA allele and haplotype frequencies in Costa Ricans from the Central Valley. (Arrieta-Bolaños E, Madrigal-Sánchez JJ, Stein JE, Órlich-Pérez P, Arrieta-Molina G, Salazar-Sánchez L, Madrigal JA, Marsh SGE, Shaw BE) Hum Immunol 2019 Jul;80(7):413-414 PMID: 31128906 SCOPUS ID: 2-s2.0-85065907284 05/28/2019    
  • 4-Locus high-resolution HLA allele and haplotype frequencies in Costa Ricans from Guanacaste. (Arrieta-Bolaños E, Madrigal-Sánchez JJ, Stein JE, Arrieta-Molina G, Salazar-Sánchez L, Madrigal JA, Marsh SGE, Shaw BE) Hum Immunol 2019 Jul;80(7):415-416 PMID: 31126638 SCOPUS ID: 2-s2.0-85065836348 05/28/2019    
  • 4-Locus high-resolution HLA allele and haplotype frequencies in Costa Ricans from African-Caribbean descent. (Arrieta-Bolaños E, Madrigal-Sánchez JJ, Stein JE, Arrieta-Molina G, Grant S, Salazar-Sánchez L, Madrigal JA, Marsh SGE, Shaw BE) Hum Immunol 2019 Jul;80(7):411-412 PMID: 31122741 SCOPUS ID: 2-s2.0-85065793873 05/28/2019       2 Citations
  • 4-Locus high-resolution HLA allele and haplotype frequencies in admixed population from Nicaragua. (Arrieta-Bolaños E, Madrigal-Sánchez JJ, Stein JE, Moreira-Espinoza MJ, Paredes-Carias E, Vanegas-Padilla Y, Salazar-Sánchez L, Madrigal JA, Marsh SGE, Shaw BE) Hum Immunol 2019 Jul;80(7):417-418 PMID: 31122740 SCOPUS ID: 2-s2.0-85065818406 05/28/2019    
  • Importance of Assessing Patient-Reported Outcomes With Salvage Autologous Transplantation in Relapsed Multiple Myeloma. (Shaw BE, D'Souza A, Lee SJ) J Clin Oncol 2019 Jul 01;37(19):1598-1600 PMID: 31084545 PMCID: PMC6879316 SCOPUS ID: 2-s2.0-85068887640 05/16/2019       1 Citation
  • Transplant center practices for psychosocial assessment and management of pediatric hematopoietic stem cell donors. (Wiener L, Hoag JA, Pelletier W, Shah NN, Shaw BE, Pulsipher MA, Bruce J, Bader P, Willasch AM, Dalissier A, Guilcher G, Anthias C, Confer DL, Sees JA, Logan B, Switzer GE) Bone Marrow Transplant 2019 Nov;54(11):1780-1788 PMID: 30971776 PMCID: PMC6961459 SCOPUS ID: 2-s2.0-85064094294 04/12/2019       12 Citations
  • Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study. (Mayor NP, Hayhurst JD, Turner TR, Szydlo RM, Shaw BE, Bultitude WP, Sayno JR, Tavarozzi F, Latham K, Anthias C, Robinson J, Braund H, Danby R, Perry J, Wilson MC, Bloor AJ, McQuaker IG, MacKinnon S, Marks DI, Pagliuca A, Potter MN, Potter VT, Russell NH, Thomson KJ, Madrigal JA, Marsh SGE) Biol Blood Marrow Transplant 2019 Mar;25(3):443-450 PMID: 30935664 SCOPUS ID: 2-s2.0-85061186899 04/03/2019       112 Citations
  • Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. (Chen YB, Le-Rademacher J, Brazauskas R, Kiefer DM, Hamadani M, DiPersio JF, Litzow MR, Craig M, Horwitz ME, Artz AS, McClune BL, Fernandez HF, Duong HK, Kobusingye H, Proue M, Drexler RJ, Horowitz MM, Shaw BE, Miller JP, Hosoba S, Waller EK, Devine SM) Blood Adv 2019 Mar 26;3(6):875-883 PMID: 30890544 PMCID: PMC6436017 SCOPUS ID: 2-s2.0-85072746485 03/21/2019       35 Citations
  • Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. (Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N) Bone Marrow Transplant 2019 May;54(5):782-783 PMID: 30809032 SCOPUS ID: 2-s2.0-85062277875 02/28/2019       1 Citation
  • A Conceptual Framework and Key Research Questions in Educational Needs of Blood and Marrow Transplantation Patients, Caregivers, and Families. (Schoemans HM, Finn L, Foster J, Roche-Green A, Bevans M, Kullberg S, Lee E, Sargeant C, Schatz BA, Scheeler K, Shaw BE, Shereck E, Murphy EA, Burns LJ, Schmit-Pokorny K) Biol Blood Marrow Transplant 2019 Jul;25(7):1416-1423 PMID: 30796997 SCOPUS ID: 2-s2.0-85063970442 02/24/2019       17 Citations
  • "Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries". (Aljurf M, Weisdorf D, Alfraih F, Szer J, Müller C, Confer D, Hashmi S, Kröger N, Shaw BE, Greinix H, Kharfan-Dabaja MA, Foeken L, Seber A, Ahmed S, El-Jawahri A, Al-Awwami M, Atsuta Y, Pasquini M, Hanbali A, Alzahrani H, Okamoto S, Gluckman E, Mohty M, Kodera Y, Horowitz M, Niederwieser D, El Fakih R) Bone Marrow Transplant 2019 Aug;54(8):1179-1188 PMID: 30778127 PMCID: PMC6760540 SCOPUS ID: 2-s2.0-85061755380 02/20/2019       65 Citations
  • The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time. (Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE) Biol Blood Marrow Transplant 2019 Jul;25(7):1325-1330 PMID: 30716454 PMCID: PMC6615955 SCOPUS ID: 2-s2.0-85062227022 02/05/2019       22 Citations
  • Graft Versus Host Disease Clinical Trials: Is it Time for Patients Centered Outcomes to Be the Primary Objective? (Shaw BE) Curr Hematol Malig Rep 2019 Feb;14(1):22-30 PMID: 30637541 PMCID: PMC6408224 SCOPUS ID: 2-s2.0-85060182293 01/15/2019       13 Citations
  • Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE) Biol Blood Marrow Transplant 2019 May;25(5):955-964 PMID: 30605731 PMCID: PMC6511296 SCOPUS ID: 2-s2.0-85061429566 01/04/2019       10 Citations
  • Patient and donor selection and workup for hematopoietic cell transplantation (Shaw BE) Hematopoietic Cell Transplantation for Malignant Conditions 1 January 2019:85-97 SCOPUS ID: 2-s2.0-85082285239 01/01/2019    
  • Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. (Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M) Biol Blood Marrow Transplant 2019 Apr;25(4):827-833 PMID: 30572109 SCOPUS ID: 2-s2.0-85059680507 12/21/2018       33 Citations
  • Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. (Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Al-Khinji A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N) Bone Marrow Transplant 2019 May;54(5):648-661 PMID: 30531955 PMCID: PMC6497536 SCOPUS ID: 2-s2.0-85058153231 12/12/2018       22 Citations
  • Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. (Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petriček I) Bone Marrow Transplant 2019 May;54(5):662-673 PMID: 30531954 SCOPUS ID: 2-s2.0-85058160164 12/12/2018       73 Citations
  • Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation. (Inamoto Y, Petriček I, Burns L, Chhabra S, DeFilipp Z, Hematti P, Rovó A, Schears R, Shah A, Agrawal V, Ahmed A, Ahmed I, Ali A, Aljurf M, Alkhateeb H, Beitinjaneh A, Bhatt N, Buchbinder D, Byrne M, Callander N, Fahnehjelm K, Farhadfar N, Gale RP, Ganguly S, Hashmi S, Hildebrandt GC, Horn E, Jakubowski A, Kamble RT, Law J, Lee C, Nathan S, Penack O, Pingali R, Prasad P, Pulanic D, Rotz S, Shreenivas A, Steinberg A, Tabbara K, Tichelli A, Wirk B, Yared J, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Valdés-Sanz N) Biol Blood Marrow Transplant 2019 May;25(5):e145-e154 PMID: 30521975 PMCID: PMC6511311 SCOPUS ID: 2-s2.0-85059228103 12/07/2018       20 Citations
  • Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. (Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, Liu H, Rowley S, Schoemans H, Shah A, Lupo Stanghellini MT, Agrawal V, Ahmed I, Ali A, Bhatt N, Byrne M, Chhabra S, DeFilipp Z, Fahnehjelm K, Farhadfar N, Horn E, Lee C, Nathan S, Penack O, Prasad P, Rotz S, Rovó A, Yared J, Pavletic S, Basak GW, Battiwalla M, Duarte R, Savani BN, Flowers MED, Shaw BE, Petriček I) Biol Blood Marrow Transplant 2019 Feb;25(2):e46-e54 PMID: 30481594 PMCID: PMC6362842 SCOPUS ID: 2-s2.0-85059172514 11/28/2018       39 Citations
  • Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. (Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2019 Apr;25(4):699-711 PMID: 30423480 PMCID: PMC6453753 SCOPUS ID: 2-s2.0-85058455309 11/14/2018       18 Citations
  • In reply: NOD2/CARD15 Polymorphisms in Allogeneic Stem-Cell Transplantation From Unrelated Donors: T Depletion Matters. (Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S, et al.) J Clin Oncol 11/07/2018    
  • Practical hematopoietic stem cell transplantation. (Shaw BE) Bone Marrow Transplant 11/07/2018    
  • Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. (Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE) Haematologica 2019 Apr;104(4):844-854 PMID: 30381298 PMCID: PMC6442962 SCOPUS ID: 2-s2.0-85064008651 11/02/2018       21 Citations
  • Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR). (Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, Salit RB, Syrjala KL, Talano JM, Shaw BE) Cancer 2019 Jan 01;125(1):144-152 PMID: 30368771 PMCID: PMC6310211 SCOPUS ID: 2-s2.0-85055708918 10/29/2018       23 Citations
  • Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation. (Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, T Kamble R, DeFilipp Z, Jacobsohn DA, Ringden O, Inamoto Y, A Kasow K, Buchbinder D, Shaw P, Hematti P, Schears R, Badawy SM, Lazarus HM, Bhatt N, Horn B, Chhabra S, M Page K, Hamilton B, Hildebrandt GC, Yared JA, Agrawal V, M Beitinjaneh A, Majhail N, Kindwall-Keller T, Olsson RF, Schoemans H, Gale RP, Ganguly S, A Ahmed I, Schouten HC, L Liesveld J, Khera N, Steinberg A, Shah AJ, Solh M, Marks DI, Rybka W, Aljurf M, Dietz AC, Gergis U, George B, Seo S, Flowers MED, Battiwalla M, Savani BN, Riches ML, Wingard JR) Biol Blood Marrow Transplant 2019 Feb;25(2):362-368 PMID: 30287390 PMCID: PMC6339825 SCOPUS ID: 2-s2.0-85055972080 10/06/2018       51 Citations
  • Current use of biosimilar G-CSF for haematopoietic stem cell mobilisation. (Pahnke S, Egeland T, Halter J, Hägglund H, Shaw BE, Woolfrey AE, Szer J, Working Group Medical of the World Marrow Donor Association) Bone Marrow Transplant 2019 Jun;54(6):858-866 PMID: 30283148 SCOPUS ID: 2-s2.0-85054361979 10/05/2018       20 Citations
  • Rates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers. (Liang J, Lee SJ, Storer BE, Shaw BE, Chow EJ, Flowers ME, Krakow EF, Bar M, Syrjala KL, Salit RB, Kurukulasuriya CE, Jim HSL) Biol Blood Marrow Transplant 2019 Jan;25(1):145-150 PMID: 30098393 PMCID: PMC6310630 SCOPUS ID: 2-s2.0-85053037794 08/12/2018       40 Citations
  • Motives for joining an unrelated HSC donor registry: description, categorization, and association with donor availability. (La Casta AH, Shaw BE, Anthias C, Bruce JG, Pastorek G, Billen A, O'Leary A, Switzer GE) Bone Marrow Transplant 2019 Mar;54(3):425-431 PMID: 30087465 SCOPUS ID: 2-s2.0-85052526938 08/09/2018       9 Citations
  • Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. (Radivoyevitch T, Dean RM, Shaw BE, Brazauskas R, Tecca HR, Molenaar RJ, Battiwalla M, Savani BN, Flowers MED, Cooke KR, Hamilton BK, Kalaycio M, Maciejewski JP, Ahmed I, Akpek G, Bajel A, Buchbinder D, Cahn JY, D'Souza A, Daly A, DeFilipp Z, Ganguly S, Hamadani M, Hayashi RJ, Hematti P, Inamoto Y, Khera N, Kindwall-Keller T, Landau H, Lazarus H, Majhail NS, Marks DI, Olsson RF, Seo S, Steinberg A, William BM, Wirk B, Yared JA, Aljurf M, Abidi MH, Allewelt H, Beitinjaneh A, Cook R, Cornell RF, Fay JW, Hale G, Chakrabarty JH, Jodele S, Kasow KA, Mahindra A, Malone AK, Popat U, Rizzo JD, Schouten HC, Warwick AB, Wood WA, Sekeres MA, Litzow MR, Gale RP, Hashmi SK) Leuk Res 2018 Nov;74:130-136 PMID: 30055822 PMCID: PMC6219911 SCOPUS ID: 2-s2.0-85050340275 07/30/2018       61 Citations
  • In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance. (Arrieta-Bolaños E, Crivello P, Shaw BE, Ahn KW, Wang HL, Verneris MR, Hsu KC, Pidala J, Lee SJ, Fleischhauer K, Spellman SR) Blood Adv 2018 Jul 24;2(14):1773-1783 PMID: 30042143 PMCID: PMC6058232 SCOPUS ID: 2-s2.0-85071081213 07/26/2018       30 Citations
  • Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. (Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, Savasan S, Hudspeth MP, Adams RH, Lewis VA, Kheradpour A, Kasow KA, Gillio AP, Haight AE, Bhatia M, Bambach BJ, Haines HL, Quigg TC, Greiner RJ, Talano JM, Delgado DC, Cheerva A, Gowda M, Ahuja S, Ozkaynak M, Mitchell D, Schultz KR, Fry TJ, Loeb DM, Pulsipher MA) Biol Blood Marrow Transplant 2018 Oct;24(10):2040-2046 PMID: 29933069 PMCID: PMC6239928 SCOPUS ID: 2-s2.0-85050818070 06/23/2018       39 Citations
  • Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation. (Bhatt NS, Brazauskas R, Tecca HR, Vogel J, Mattila D, Lee SJ, Horowitz MM, Rizzo JD, Shaw BE) J Pediatr Hematol Oncol 2019 Apr;41(3):233-237 PMID: 29923857 PMCID: PMC6301126 SCOPUS ID: 2-s2.0-85049213444 06/21/2018       6 Citations
  • EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. (Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, Shaw BE, Flowers ME, Ruutu T, Greinix H, Holler E, Basak G, Duarte RF, Pavletic SZ, EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the “EBMT−NIH (National Institutes of Health)−CIBMTR (Center for International Blood and Marrow Transplant Research) GvHD Task Force”) Bone Marrow Transplant 2018 Nov;53(11):1401-1415 PMID: 29872128 PMCID: PMC6786777 SCOPUS ID: 2-s2.0-85048047540 06/07/2018       486 Citations
  • Patient-reported outcomes and health status associated with chronic graft-versus-host disease. (Lee SJ, Onstad L, Chow EJ, Shaw BE, Jim HSL, Syrjala KL, Baker KS, Buckley S, Flowers ME) Haematologica 2018 Sep;103(9):1535-1541 PMID: 29858386 PMCID: PMC6119141 SCOPUS ID: 2-s2.0-85052852652 06/03/2018       92 Citations
  • Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection. (Fleischhauer K, Hsu KC, Shaw BE) Bone Marrow Transplant 2018 Dec;53(12):1498-1507 PMID: 29795435 PMCID: PMC7286200 SCOPUS ID: 2-s2.0-85047352097 05/26/2018       10 Citations
  • Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium. (Nemecek ER, Hilger RA, Adams A, Shaw BE, Kiefer D, Le-Rademacher J, Levine JE, Yanik G, Leung W, Talano JA, Haut P, Delgado D, Kapoor N, Petrovic A, Adams R, Hanna R, Rangarajan H, Dalal J, Chewning J, Verneris MR, Epstein S, Burroughs L, Perez-Albuerne ED, Pulsipher MA, Delaney C) Biol Blood Marrow Transplant 2018 Aug;24(8):1651-1656 PMID: 29753157 PMCID: PMC6108922 SCOPUS ID: 2-s2.0-85047460893 05/13/2018       22 Citations
  • High-resolution HLA allele and haplotype frequencies in majority and minority populations of Costa Rica and Nicaragua: Differential admixture proportions in neighboring countries. (Arrieta-Bolaños E, Madrigal-Sánchez JJ, Stein JE, Órlich-Pérez P, Moreira-Espinoza MJ, Paredes-Carias E, Vanegas-Padilla Y, Salazar-Sánchez L, Madrigal JA, Marsh SGE, Shaw BE) HLA 2018 Jun;91(6):514-529 PMID: 29687625 SCOPUS ID: 2-s2.0-85048044969 04/25/2018       21 Citations
  • Peripheral Blood Grafts for T Cell-Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. (Raj RV, Hamadani M, Szabo A, Pasquini MC, Shah NN, Drobyski WR, Shaw BE, Saber W, Rizzo JD, Jerkins J, Fenske TS, D'Souza A, Dhakal B, Zhang C, Konings S, Hari PN, Chhabra S) Biol Blood Marrow Transplant 2018 Aug;24(8):1664-1670 PMID: 29680516 SCOPUS ID: 2-s2.0-85047194888 04/24/2018       47 Citations
  • Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective. (Badar T, Hari P, Chhabra S, Dhakal B, Drobyski WR, Fenske TS, Hamadani M, Pasquini M, Saber W, Shah NN, Shaw BE, D'Souza A) Bone Marrow Transplant 2018 Sep;53(9):1210-1213 PMID: 29679076 SCOPUS ID: 2-s2.0-85045751124 04/22/2018       7 Citations
  • Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. (Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS) Bone Marrow Transplant 2018 Oct;53(10):1278-1287 PMID: 29581480 PMCID: PMC6158112 SCOPUS ID: 2-s2.0-85044469262 03/28/2018       37 Citations
  • Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. (D'Souza A, Millard H, Knight J, Brazauskas R, Lee SJ, Flynn KE, Rizzo JD, Shaw BE) Bone Marrow Transplant 2018 Aug;53(8):1079-1082 PMID: 29515251 PMCID: PMC6098949 SCOPUS ID: 2-s2.0-85042917359 03/09/2018       8 Citations
  • The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. (Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS, Blood and Marrow Transplant Clinical Trials Network) Biol Blood Marrow Transplant 2018 Jul;24(7):1322-1340 PMID: 29471034 PMCID: PMC6045977 SCOPUS ID: 2-s2.0-85049143550 02/23/2018       106 Citations
  • Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most. (Shaw BE, Logan BR, Spellman SR, Marsh SGE, Robinson J, Pidala J, Hurley C, Barker J, Maiers M, Dehn J, Wang H, Haagenson M, Porter D, Petersdorf EW, Woolfrey A, Horowitz MM, Verneris M, Hsu KC, Fleischhauer K, Lee SJ) Biol Blood Marrow Transplant 2018 May;24(5):1049-1056 PMID: 29454040 PMCID: PMC5953795 SCOPUS ID: 2-s2.0-85043996138 02/18/2018       165 Citations
  • Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation. (Burns LJ, Abbetti B, Arnold SD, Bender J, Doughtie S, El-Jawahiri A, Gee G, Hahn T, Horowitz MM, Johnson S, Juckett M, Krishnamurit L, Kullberg S, LeMaistre CF, Loren A, Majhail NS, Murphy EA, Rizzo D, Roche-Green A, Saber W, Schatz BA, Schmit-Pokorny K, Shaw BE, Syrjala KL, Tierney DK, Ullrich C, Vanness DJ, Wood WA, Denzen EM) Biol Blood Marrow Transplant 2018 Jun;24(6):1111-1118 PMID: 29408289 PMCID: PMC5993588 SCOPUS ID: 2-s2.0-85043400078 02/07/2018       30 Citations
  • Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease. (Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Dunn R, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M) Haematologica 2018 Apr;103(4):717-727 PMID: 29351985 PMCID: PMC5865423 SCOPUS ID: 2-s2.0-85044420638 01/21/2018       47 Citations
  • Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. (Buchbinder D, Kelly DL, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick AB, Wirk BM, Yi J, Battiwalla M, Flowers MDE, Savani B, Shaw BE) Bone Marrow Transplant 2018 May;53(5):535-555 PMID: 29343837 PMCID: PMC5985976 SCOPUS ID: 2-s2.0-85040684681 01/19/2018       97 Citations
  • Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint. (Shaw BE) Blood Adv 2017 Feb 14;1(6):401-406 PMID: 29296955 PMCID: PMC5738987 SCOPUS ID: 2-s2.0-85029222788 01/04/2018       16 Citations
  • Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma. (Myers RM, Hill BT, Shaw BE, Kim S, Millard HR, Battiwalla M, Majhail NS, Buchbinder D, Lazarus HM, Savani BN, Flowers MED, D'Souza A, Ehrhardt MJ, Langston A, Yared JA, Hayashi RJ, Daly A, Olsson RF, Inamoto Y, Malone AK, DeFilipp Z, Margossian SP, Warwick AB, Jaglowski S, Beitinjaneh A, Fung H, Kasow KA, Marks DI, Reynolds J, Stockerl-Goldstein K, Wirk B, Wood WA, Hamadani M, Satwani P) Cancer 2018 Feb 15;124(4):816-825 PMID: 29125192 PMCID: PMC5871233 SCOPUS ID: 2-s2.0-85033592450 11/11/2017       54 Citations
  • PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors. (Shaw BE, Syrjala KL, Onstad LE, Chow EJ, Flowers ME, Jim H, Baker KS, Buckley S, Fairclough DL, Horowitz MM, Lee SJ) Cancer 2018 Feb 15;124(4):841-849 PMID: 29072787 PMCID: PMC5800994 SCOPUS ID: 2-s2.0-85032287599 10/27/2017       62 Citations
  • Donation of peripheral blood stem cells to unrelated strangers: A thematic analysis. (Billen A, Madrigal JA, Scior K, Shaw BE, Strydom A) PLoS One 2017;12(10):e0186438 PMID: 29069088 PMCID: PMC5656410 SCOPUS ID: 2-s2.0-85032212684 10/27/2017       13 Citations
  • Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less. (Stroncek DF, Shaw BE, Logan BR, Kiefer DM, Savani BN, Anderlini P, Bredeson CN, Hematti P, Ganguly S, Diaz MA, Abdel-Azim H, Ahmed I, Maharaj D, Seftel M, Beitinjaneh A, Seo S, Yared JA, Halter J, O'Donnell PV, Hale GA, DeFilipp Z, Lazarus H, Liesveld JL, Zhou Z, Munshi P, Olsson RF, Kasow KA, Szer J, Switzer GE, Chitphakdithai P, Shah N, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2018 Jan;24(1):175-184 PMID: 28958894 PMCID: PMC5743544 SCOPUS ID: 2-s2.0-85033230771 09/30/2017       5 Citations
  • Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation. (Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M, DeFilipp Z, Gabriel M, Mahindra A, Norkin M, Schoemans H, Shah AJ, Ahmed I, Atsuta Y, Basak GW, Beattie S, Bhella S, Bredeson C, Bunin N, Dalal J, Daly A, Gajewski J, Gale RP, Galvin J, Hamadani M, Hayashi RJ, Adekola K, Law J, Lee CJ, Liesveld J, Malone AK, Nagler A, Naik S, Nishihori T, Parsons SK, Scherwath A, Schofield HL, Soiffer R, Szer J, Twist I, Warwick A, Wirk BM, Yi J, Battiwalla M, Flowers ME, Savani B, Shaw BE) Biol Blood Marrow Transplant 2018 Feb;24(2):228-241 PMID: 28939455 PMCID: PMC5768142 SCOPUS ID: 2-s2.0-85034852162 09/25/2017       58 Citations
  • Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. (Shaw BE, Brazauskas R, Millard HR, Fonstad R, Flynn KE, Abernethy A, Vogel J, Petroske C, Mattila D, Drexler R, Lee SJ, Horowitz MM, Rizzo JD) Cancer 2017 Dec 01;123(23):4687-4700 PMID: 28817182 PMCID: PMC5693638 SCOPUS ID: 2-s2.0-85034085598 08/18/2017       53 Citations
  • Etanercept and Corticosteroid Therapy for the Treatment of Late-Onset Idiopathic Pneumonia Syndrome. (Thompson J, Yin Z, D'Souza A, Fenske T, Hamadani M, Hari P, Rizzo JD, Pasquini M, Saber W, Shah N, Shaw BE, Shahir K, Banerjee A, Drobyski WR) Biol Blood Marrow Transplant 2017 Nov;23(11):1955-1960 PMID: 28757436 SCOPUS ID: 2-s2.0-85028446880 08/02/2017       31 Citations
  • Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. (Jerkins JH, Hamadani M, Zook F, Epperla N, Shaw BE, Saber W, Rizzo JD, Pasquini M, Chhabra S, Drobyski WR, Hari PN, Shah NN) Am J Hematol 2017 Oct;92(10):E610-E611 PMID: 28699171 SCOPUS ID: 2-s2.0-85026445343 07/13/2017       7 Citations
  • Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation. (Berro M, Arbelbide JA, Rivas MM, Basquiera AL, Ferini G, Vitriu A, Foncuberta C, Fernandez Escobar N, Requejo A, Milovic V, Yantorno S, Szelagoswki M, Martinez Rolon J, Bentolila G, Garcia JJ, Garcia P, Caeiro G, Castro M, Jaimovich G, Palmer S, Trucco JI, Bet LA, Shaw BE, Kusminsky GD) Biol Blood Marrow Transplant 2017 Oct;23(10):1646-1650 PMID: 28669923 SCOPUS ID: 2-s2.0-85027226120 07/04/2017       53 Citations
  • HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities. (Fleischhauer K, Shaw BE) Blood 2017 Aug 31;130(9):1089-1096 PMID: 28667011 PMCID: PMC12247121 SCOPUS ID: 2-s2.0-85028885981 07/02/2017       76 Citations
  • Parent versus child donor perceptions of the bone marrow donation experience. (Switzer GE, Bruce J, Pastorek G, Kiefer DM, Kobusingye H, Drexler R, Besser RAM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Wiener L, Packman W, Varni JW, Pulsipher MA) Bone Marrow Transplant 2017 Sep;52(9):1338-1341 PMID: 28650449 PMCID: PMC5933883 SCOPUS ID: 2-s2.0-85028813659 06/27/2017       11 Citations
  • Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation. (Fleischhauer K, Ahn KW, Wang HL, Zito L, Crivello P, Müller C, Verneris M, Shaw BE, Pidala J, Oudshorn M, Lee SJ, Spellman SR) Bone Marrow Transplant 2017 Sep;52(9):1280-1287 PMID: 28581467 PMCID: PMC5968827 SCOPUS ID: 2-s2.0-85028864903 06/06/2017       21 Citations
  • Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age. (Vrooman LM, Millard HR, Brazauskas R, Majhail NS, Battiwalla M, Flowers ME, Savani BN, Akpek G, Aljurf M, Bajwa R, Baker KS, Beitinjaneh A, Bitan M, Buchbinder D, Chow E, Dandoy C, Dietz AC, Diller L, Gale RP, Hashmi SK, Hayashi RJ, Hematti P, Kamble RT, Kasow KA, Kletzel M, Lazarus HM, Malone AK, Marks DI, O'Brien TA, Olsson RF, Ringden O, Seo S, Steinberg A, Yu LC, Warwick A, Shaw B, Duncan C) Biol Blood Marrow Transplant 2017 Aug;23(8):1327-1334 PMID: 28461213 PMCID: PMC5666571 SCOPUS ID: 2-s2.0-85021731451 05/04/2017       53 Citations
  • Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes. (Hamblin A, Greenfield DM, Gilleece M, Salooja N, Kenyon M, Morris E, Glover N, Miller P, Braund H, Peniket A, Shaw BE, Snowden JA) Bone Marrow Transplant 2017 Jun;52(6):889-894 PMID: 28436977 SCOPUS ID: 2-s2.0-85020485269 04/25/2017       10 Citations
  • Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR). (Gabriel M, Shaw BE, Brazauskas R, Chen M, Margolis DA, Sengelov H, Dahlberg A, Ahmed IA, Delgado D, Lazarus HM, Gibson B, Myers KC, Kamble RT, Abdel-Mageed A, Li CK, Flowers MED, Battiwalla M, Savani BN, Majhail N, Shaw PJ) Biol Blood Marrow Transplant 2017 Aug;23(8):1320-1326 PMID: 28411175 PMCID: PMC5518678 SCOPUS ID: 2-s2.0-85019572284 04/16/2017       9 Citations
  • Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation. (Berro M, Palau Nagore MV, Rivas MM, Longo P, Foncuberta C, Vitriú A, Remaggi G, Martínez Rolon J, Jaimovich G, Requejo A, Feldman L, Padros K, Rodríguez MB, Shaw BE, Larripa I, Belli CB, Kusminsky GD) Bone Marrow Transplant 2017 May;52(5):739-744 PMID: 28134923 SCOPUS ID: 2-s2.0-85010931341 01/31/2017       6 Citations
  • Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants. (Shaw BE, Mayor NP, Szydlo RM, Bultitude WP, Anthias C, Kirkland K, Perry J, Clark A, Mackinnon S, Marks DI, Pagliuca A, Potter MN, Russell NH, Thomson K, Madrigal JA, Marsh SGE) Bone Marrow Transplant 2017 May;52(5):717-725 PMID: 28092349 SCOPUS ID: 2-s2.0-85009812316 01/17/2017       59 Citations
  • HLA typing and implications (Shaw BE, Spellman SR) Clinical Manual of Blood and Bone Marrow Transplantation 1 January 2017:9-18 SCOPUS ID: 2-s2.0-85218374510 01/01/2017    
  • CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. (Locke FL, Pidala J, Storer B, Martin PJ, Pulsipher MA, Chauncey TR, Jacobsen N, Kröger N, Walker I, Light S, Shaw BE, Beato F, Laport GG, Nademanee A, Keating A, Socie G, Anasetti C) Biol Blood Marrow Transplant 2017 Mar;23(3):405-411 PMID: 28007665 PMCID: PMC6716167 SCOPUS ID: 2-s2.0-85009726306 12/23/2016       19 Citations
  • Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell Donors. (Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, van Walraven SM, Wiener L, Packman W, Varni JW, Pulsipher MA) J Pediatr 2016 Nov;178:164-170.e1 PMID: 27522440 PMCID: PMC5085860 SCOPUS ID: 2-s2.0-84994322338 10/30/2016       27 Citations
  • Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study. (Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA) Biol Blood Marrow Transplant 2017 Jan;23(1):165-171 PMID: 27751935 PMCID: PMC5182103 SCOPUS ID: 2-s2.0-85006356488 10/19/2016       10 Citations
  • Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections. (Raj RV, Hari P, Pasquini M, Epperla N, D'Souza A, Fenske T, Shaw BE, Rizzo JD, Drobyski W, Hamadani M) Bone Marrow Transplant 2016 Dec;51(12):1602-1604 PMID: 27595288 SCOPUS ID: 2-s2.0-84991038636 09/07/2016       13 Citations
  • Variations in practice in UK transplant centers: results of a related donor care survey. (Anthias C, Peniket A, Kirkland K, Madrigal JA, Shaw BE) Bone Marrow Transplant 2016 Dec;51(12):1612-1614 PMID: 27595287 SCOPUS ID: 2-s2.0-84990965377 09/07/2016       2 Citations
  • National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report. (Shaw BE, Hahn T, Martin PJ, Mitchell SA, Petersdorf EW, Armstrong GT, Shelburne N, Storer BE, Bhatia S) Biol Blood Marrow Transplant 2017 Jan;23(1):10-23 PMID: 27590102 PMCID: PMC5182148 SCOPUS ID: 2-s2.0-84994430629 09/04/2016       20 Citations
  • Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. (DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers ME, Savani BN, Shaw BE) Bone Marrow Transplant 2017 Feb;52(2):173-182 PMID: 27548466 PMCID: PMC5288134 SCOPUS ID: 2-s2.0-84983515188 08/23/2016       64 Citations
  • Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial. (Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C) JAMA Oncol 2016 Dec 01;2(12):1583-1589 PMID: 27532508 PMCID: PMC5145732 SCOPUS ID: 2-s2.0-85013156188 08/18/2016       118 Citations
  • Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT. (DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE, CIBMTR Late Effects and Quality of Life Working Committee, EBMT Complications and Quality of Life Working Party) Biol Blood Marrow Transplant 2016 Aug;22(8):1493-1503 PMID: 27184625 PMCID: PMC4949101 SCOPUS ID: 2-s2.0-84981340623 05/18/2016       60 Citations
  • Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN. (Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE) Bone Marrow Transplant 2016 Sep;51(9):1173-9 PMID: 27159181 SCOPUS ID: 2-s2.0-84966474594 05/10/2016       44 Citations
  • Safety of Living Donation of Hematopoietic Stem Cells. (Szer J, Elmoazzen H, Fechter M, Hwang W, Korhonen M, Miller J, Mengling T, Shaw B, Stein J) Transplantation 2016 Jun;100(6):1329-31 PMID: 27136264 SCOPUS ID: 2-s2.0-84964699497 05/03/2016       7 Citations
  • Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation. (Li Z, Rubinstein SM, Thota R, Savani M, Brissot E, Shaw BE, Majhail NS, Mohty M, Savani BN) Biol Blood Marrow Transplant 2016 Aug;22(8):1368-1375 PMID: 27095688 SCOPUS ID: 2-s2.0-84973931467 04/21/2016       65 Citations
  • BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. (Dignan FL, Clark A, Aitken C, Gilleece M, Jayakar V, Krishnamurthy P, Pagliuca A, Potter MN, Shaw B, Skinner R, Turner A, Wynn RF, Coyle P, Haemato-oncology Task Force of the British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation and the UK Clinical Virology Network) Br J Haematol 2016 May;173(3):380-93 PMID: 27060988 PMCID: PMC7161808 SCOPUS ID: 2-s2.0-84963770967 04/12/2016       49 Citations
  • Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned. (Sorensen BS, Szer J, Shaw B, Korhonen M, Mengling T, Fechter M, Elmoazzen H, Lindberg B, Chapman J, Nørgaard JM, Foeken L, Hwang WY, Nielsen B) Bone Marrow Transplant 2016 Jul;51(7):1016-8 PMID: 26974269 SCOPUS ID: 2-s2.0-84961230917 03/15/2016       12 Citations
  • Harvests from bone marrow donors who weigh less than their recipients are associated with a significantly increased probability of a suboptimal harvest yield. (Anthias C, Billen A, Arkwright R, Szydlo RM, Madrigal JA, Shaw BE) Transfusion 2016 May;56(5):1052-7 PMID: 26898844 SCOPUS ID: 2-s2.0-84969425031 02/24/2016       20 Citations
  • Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and Eurocord. (Snowden JA, Danby R, Ruggeri A, Marks DI, Hough RE, Pagliuca A, Potter M, Russell N, Craddock C, Clark A, Miller P, Cook G, Gluckman E, Shaw BE, Rocha V) Br J Haematol 2016 Feb;172(3):478-81 PMID: 26708833 SCOPUS ID: 2-s2.0-84955681701 12/29/2015       1 Citation
  • Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors. (Arrieta-Bolaños E, Mayor NP, Marsh SG, Madrigal JA, Apperley JF, Kirkland K, Mackinnon S, Marks DI, McQuaker G, Perry J, Potter MN, Russell NH, Thomson K, Shaw BE) Haematologica 2016 Mar;101(3):382-90 PMID: 26611472 PMCID: PMC4815730 SCOPUS ID: 2-s2.0-84959262241 11/28/2015       8 Citations
  • Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. (Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV) Biol Blood Marrow Transplant 2016 Mar;22(3):520-7 PMID: 26597080 PMCID: PMC4760616 SCOPUS ID: 2-s2.0-84954290281 11/26/2015       14 Citations
  • European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards. (Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE) Biol Blood Marrow Transplant 2016 Mar;22(3):514-9 PMID: 26597079 PMCID: PMC4760354 SCOPUS ID: 2-s2.0-84954288117 11/26/2015       19 Citations
  • Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols. (Hough R, Danby R, Russell N, Marks D, Veys P, Shaw B, Wynn R, Vora A, Mackinnon S, Peggs KS, Crawley C, Craddock C, Pagliuca A, Cook G, Snowden JA, Clark A, Marsh J, Querol S, Parkes G, Braund H, Rocha V) Br J Haematol 2016 Feb;172(3):360-70 PMID: 26577457 SCOPUS ID: 2-s2.0-84955757207 11/19/2015       81 Citations
  • Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening. (Lee JB, Billen A, Lown RN, Potter MN, Craddock CF, de Lavallade H, Shaw BE, Sharpe CC) Bone Marrow Transplant 2016 Feb;51(2):286-7 PMID: 26437069 SCOPUS ID: 2-s2.0-84956896324 10/06/2015       7 Citations
  • Sexual health in hematopoietic stem cell transplant recipients. (Li Z, Mewawalla P, Stratton P, Yong AS, Shaw BE, Hashmi S, Jagasia M, Mohty M, Majhail NS, Savani BN, Rovó A) Cancer 2015 Dec 01;121(23):4124-31 PMID: 26372459 PMCID: PMC5014908 SCOPUS ID: 2-s2.0-84948569699 09/16/2015       64 Citations
  • Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. (Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE) Bone Marrow Transplant 2016 Jan;51(1):83-8 PMID: 26367222 PMCID: PMC4570237 SCOPUS ID: 2-s2.0-84953366034 09/15/2015       34 Citations
  • Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association. (Bitan M, van Walraven SM, Worel N, Ball LM, Styczynski J, Torrabadella M, Witt V, Shaw BE, Seber A, Yabe H, Greinix HT, Peters C, Gluckman E, Rocha V, Halter J, Pulsipher MA) Biol Blood Marrow Transplant 2016 Jan;22(1):96-103 PMID: 26307344 SCOPUS ID: 2-s2.0-84959851904 08/27/2015       30 Citations
  • When Can You Discard Stem Cells? (Booth GS, Gehrie EA, Jagasia MH, Shaw BE, Savani BN) Biol Blood Marrow Transplant 2015 Nov;21(11):2033 PMID: 26253004 SCOPUS ID: 2-s2.0-84943453130 08/09/2015       2 Citations
  • Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers. (Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA) Biol Blood Marrow Transplant 2015 Oct;21(10):1830-8 PMID: 26116089 PMCID: PMC4568129 SCOPUS ID: 2-s2.0-84941317226 06/28/2015       14 Citations
  • Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients. (Sriskandarajah P, Webb K, Chisholm D, Raobaikady R, Davis K, Pepper N, Ethell ME, Potter MN, Shaw BE) Thromb J 2015;13:21 PMID: 26113804 PMCID: PMC4480444 SCOPUS ID: 2-s2.0-84933524797 06/27/2015       31 Citations
  • Secondary solid cancer screening following hematopoietic cell transplantation. (Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, Malone AK, Lupo-Stanghellini MT, Margossian SP, Muffly LS, Norkin M, Ramanathan M, Salooja N, Schoemans H, Wingard JR, Wirk B, Wood WA, Yong A, Duncan CN, Flowers ME, Majhail NS) Bone Marrow Transplant 2015 Aug;50(8):1013-23 PMID: 25822223 PMCID: PMC4989866 SCOPUS ID: 2-s2.0-84938971140 03/31/2015       161 Citations
  • Novel alleles of the transforming growth factor β-1 regulatory region and exon 1. (Arrieta-Bolaños E, Madrigal JA, Shaw BE) Tissue Antigens 2015 Jun;85(6):484-91 PMID: 25808355 SCOPUS ID: 2-s2.0-84928996252 03/27/2015       4 Citations
  • Related hematopoietic cell donor care: is there a role for unrelated donor registries? (Anthias C, van Walraven SM, Sørensen BS, de Faveri GN, Fechter M, Cornish J, Bacigalupo A, Müller C, Boo M, Shaw BE) Bone Marrow Transplant 2015 May;50(5):637-41 PMID: 25730182 SCOPUS ID: 2-s2.0-84928925735 03/03/2015       20 Citations
  • A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies. (Shaw BE, Confer DL, Hwang W, Pulsipher MA) Bone Marrow Transplant 2015 Mar;50(3):334-40 PMID: 25599171 SCOPUS ID: 2-s2.0-84938419338 01/20/2015       55 Citations
  • Predonation health-related quality of life scores predict time to recovery in hematopoietic stem cell donors. (Billen A, Madrigal JA, Strydom A, Szydlo RM, Switzer GE, Shaw BE) Biol Blood Marrow Transplant 2015 Feb;21(2):350-6 PMID: 25452034 SCOPUS ID: 2-s2.0-84920923387 12/03/2014       12 Citations
  • The impact of improved JACIE standards on the care of related BM and PBSC donors. (Anthias C, Ethell ME, Potter MN, Madrigal A, Shaw BE) Bone Marrow Transplant 2015 Feb;50(2):244-7 PMID: 25387092 SCOPUS ID: 2-s2.0-84922410998 11/12/2014       26 Citations
  • Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation. (Shaw BE, Lee F, Krishnamurthy S, Byrne JL, Seedhouse C, Mayor NP, Maldonado-Torres H, Saudemont A, Marsh SG, Madrigal JA, Russell NH) Bone Marrow Transplant 2015 Feb;50(2):237-43 PMID: 25347010 SCOPUS ID: 2-s2.0-84922410096 10/28/2014       2 Citations
  • A novel HLA-A allele, A*74:23, identified in an individual from Costa Rica. (Arrieta-Bolaños E, McWhinnie AJ, Madrigal-Sánchez JJ, Calvo L, Salazar-Sánchez L, Madrigal JA, Marsh SG, Shaw BE) Tissue Antigens 2014 Dec;84(6):583-4 PMID: 25345851 SCOPUS ID: 2-s2.0-84911382989 10/28/2014       4 Citations
  • Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis. (Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL) Biol Blood Marrow Transplant 2015 Jan;21(1):165-71 PMID: 25316111 PMCID: PMC4272878 SCOPUS ID: 2-s2.0-84927166294 10/16/2014       29 Citations
  • A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent. (Scarisbrick JJ, Dignan FL, Tulpule S, Gupta ED, Kolade S, Shaw B, Evison F, Shah G, Tholouli E, Mufti G, Pagliuca A, Malladi R, Raj K) Bone Marrow Transplant 2015 Jan;50(1):62-7 PMID: 25310308 SCOPUS ID: 2-s2.0-84920557863 10/14/2014       62 Citations
  • The frequency of HLA-B(∗)57:01 and the risk of abacavir hypersensitivity reactions in the majority population of Costa Rica. (Arrieta-Bolaños E, Madrigal JA, Marsh SG, Shaw BE, Salazar-Sánchez L) Hum Immunol 2014 Nov;75(11):1092-6 PMID: 25286002 SCOPUS ID: 2-s2.0-84908491530 10/07/2014       12 Citations
  • Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study. (Nikolousis E, Nagra S, Pearce R, Perry J, Kirkland K, Byrne J, Dignan F, Tholouli E, Gilleece M, Russell N, Littlewood T, Cook M, Peniket A, Shaw BE, Cook G, Craddock C) Bone Marrow Transplant 2015 Jan;50(1):82-6 PMID: 25285801 SCOPUS ID: 2-s2.0-84920665681 10/07/2014       9 Citations
  • Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. (Pidala J, Lee SJ, Ahn KW, Spellman S, Wang HL, Aljurf M, Askar M, Dehn J, Fernandez Viña M, Gratwohl A, Gupta V, Hanna R, Horowitz MM, Hurley CK, Inamoto Y, Kassim AA, Nishihori T, Mueller C, Oudshoorn M, Petersdorf EW, Prasad V, Robinson J, Saber W, Schultz KR, Shaw B, Storek J, Wood WA, Woolfrey AE, Anasetti C) Blood 2014 Oct 16;124(16):2596-606 PMID: 25161269 PMCID: PMC4199961 SCOPUS ID: 2-s2.0-84908131214 08/28/2014       267 Citations
  • The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface. (Lee F, Luevano M, Veys P, Yong K, Madrigal A, Shaw BE, Saudemont A) PLoS One 2014;9(7):e103254 PMID: 25050704 PMCID: PMC4106894 SCOPUS ID: 2-s2.0-84904647754 07/23/2014       10 Citations
  • Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies. (Feliu J, Clay J, Raj K, Barber L, Devlia V, Shaw B, Pagliuca A, Mufti G) Br J Haematol 2014 Nov;167(3):426-8 PMID: 24962133 SCOPUS ID: 2-s2.0-84911997363 06/26/2014       8 Citations
  • Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1. (Fleischhauer K, Fernandez-Viña MA, Wang T, Haagenson M, Battiwalla M, Baxter-Lowe LA, Ciceri F, Dehn J, Gajewski J, Hale GA, Heemskerk MB, Marino SR, McCarthy PL, Miklos D, Oudshoorn M, Pollack MS, Reddy V, Senitzer D, Shaw BE, Waller EK, Lee SJ, Spellman SR) Bone Marrow Transplant 2014 Sep;49(9):1176-83 PMID: 24955785 PMCID: PMC4154997 SCOPUS ID: 2-s2.0-85027943464 06/24/2014       31 Citations
  • Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature. (Das-Gupta E, Dignan F, Shaw B, Raj K, Malladi R, Gennery A, Bonney D, Taylor P, Scarisbrick J) Bone Marrow Transplant 2014 Oct;49(10):1251-8 PMID: 24887389 SCOPUS ID: 2-s2.0-84926407213 06/03/2014       38 Citations
  • Female donors and donors who are lighter than their recipient are less likely to meet the CD34+ cell dose requested for peripheral blood stem cell transplantation. (Billen A, Madrigal JA, Szydlo RM, Shaw BE) Transfusion 2014 Nov;54(11):2953-60 PMID: 24863396 SCOPUS ID: 2-s2.0-84912070193 05/28/2014       22 Citations
  • Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. (Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP, Shaw BE, O'Donnell PV, Majhail NS, Confer DL) Blood 2014 Jun 05;123(23):3655-63 PMID: 24735965 PMCID: PMC4047500 SCOPUS ID: 2-s2.0-84902150458 04/17/2014       113 Citations
  • Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee. (Lown RN, Philippe J, Navarro W, van Walraven SM, Philips-Johnson L, Fechter M, Pawson R, Bengtsson M, Beksac M, Field S, Yang H, Shaw BE, World Marrow Donor Association Clinical Working Group Committee) Bone Marrow Transplant 2014 Jul;49(7):880-6 PMID: 24710563 SCOPUS ID: 2-s2.0-84903881880 04/09/2014       45 Citations
  • Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD. (Dignan FL, Aguilar S, Scarisbrick JJ, Shaw BE, Potter MN, Cavenagh J, Apperley JF, Fielding AK, Pagliuca A, Raj K, Marks DI, Peniket A, Crawley C, Koh MB, Child FJ) Bone Marrow Transplant 2014 May;49(5):704-8 PMID: 24566709 SCOPUS ID: 2-s2.0-84900331512 02/26/2014       32 Citations
  • Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML. (Anthias C, Dignan FL, Morilla R, Morilla A, Ethell ME, Potter MN, Shaw BE) Bone Marrow Transplant 2014 May;49(5):679-83 PMID: 24510069 SCOPUS ID: 2-s2.0-84900303568 02/11/2014       78 Citations
  • A review of the haematopoietic stem cell donation experience: is there room for improvement? (Billen A, Madrigal JA, Shaw BE) Bone Marrow Transplant 2014 Jun;49(6):729-36 PMID: 24464144 SCOPUS ID: 2-s2.0-84902087001 01/28/2014       33 Citations
  • Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage. (Lown RN, Marsh SG, Switzer GE, Latham KA, Madrigal JA, Shaw BE) Bone Marrow Transplant 2014 Apr;49(4):525-31 PMID: 24419516 SCOPUS ID: 2-s2.0-84897500442 01/15/2014       35 Citations
  • EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. (Fox CP, Burns D, Parker AN, Peggs KS, Harvey CM, Natarajan S, Marks DI, Jackson B, Chakupurakal G, Dennis M, Lim Z, Cook G, Carpenter B, Pettitt AR, Mathew S, Connelly-Smith L, Yin JA, Viskaduraki M, Chakraverty R, Orchard K, Shaw BE, Byrne JL, Brookes C, Craddock CF, Chaganti S) Bone Marrow Transplant 2014 Feb;49(2):280-6 PMID: 24212561 SCOPUS ID: 2-s2.0-84893769793 11/12/2013       80 Citations
  • Erratum: Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: A British Society of Blood and Marrow Transplantation study (Bone Marrow Transplantation (2013) 48 (982-987) DOI: 10.1038/bmt.2012.261) (Medd PG, Peniket AJ, Littlewood TJ, Pearce R, Perry J, Kirkland KE, Shaw BE, Potter MN, Craddock CF, Milligan DW, Fielding AK, Marks DI, Cook G) Bone Marrow Transplantation October 2013;48(10):1368 SCOPUS ID: 2-s2.0-84885636451 10/01/2013    
  • Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation. (Shaw BE, Chapman J, Fechter M, Foeken L, Greinix H, Hwang W, Phillips-Johnson L, Korhonen M, Lindberg B, Navarro WH, Szer J) Bone Marrow Transplant 2013 Nov;48(12):1506-9 PMID: 23892330 SCOPUS ID: 2-s2.0-84889571725 07/31/2013       16 Citations
  • Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest. (Lown RN, Tulpule S, Russell NH, Craddock CF, Roest R, Madrigal JA, Shaw BE) Haematologica 2013 Dec;98(12):1956-63 PMID: 23812935 PMCID: PMC3856971 SCOPUS ID: 2-s2.0-84889791087 07/03/2013       4 Citations
  • Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice. (Shaw BE, Robinson J, Fleischhauer K, Madrigal JA, Marsh SG) Bone Marrow Transplant 2013 Nov;48(12):1510-2 PMID: 23811815 SCOPUS ID: 2-s2.0-84889568246 07/03/2013       29 Citations
  • Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study. (Medd PG, Peniket AJ, Littlewood TJ, Pearce R, Perry J, Kirkland KE, Shaw BE, Potter MN, Craddock CF, Milligan DW, Fielding AK, Marks DI, Cook G, British Society of Blood and Marrow Transplantation) Bone Marrow Transplant 2013 Jul;48(7):982-7 PMID: 23318533 SCOPUS ID: 2-s2.0-84880222510 01/16/2013       10 Citations
  • Biological and Genetic Aspects of Donor-Recipient Matching in HSCT. (Lange A, Raffoux C, Shaw B) Bone Marrow Res 2012;2012:212593 PMID: 23304517 PMCID: PMC3523404 01/11/2013    
  • High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD. (Dignan FL, Potter MN, Ethell ME, Taylor M, Lewis L, Brennan J, McNamara L, Evans SO, Riley U, Davies FE, Dearden CE, Morgan GJ, Shaw BE) Clin Transplant 2013;27(1):E56-63 PMID: 23278853 SCOPUS ID: 2-s2.0-84873077177 01/03/2013       34 Citations
  • 16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. (Petersdorf EW, Malkki M, Hsu K, Bardy P, Cesbron A, Dickinson A, Dubois V, Fleischhauer K, Kawase T, Madrigal A, Morishima Y, Shaw B, Spellman S, Spierings E, Stern M, Tiercy JM, Velardi A, Gooley T, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Int J Immunogenet 2013 Feb;40(1):2-10 PMID: 23279968 PMCID: PMC3887040 SCOPUS ID: 2-s2.0-84872267341 01/03/2013       25 Citations
  • A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors. (Dignan FL, Manwani R, Potter MN, Ethell ME, Leonard H, Brennan J, Baker J, Shaw BE) Clin Transplant 2013;27(1):E1-2 PMID: 23215823 SCOPUS ID: 2-s2.0-84873095231 12/12/2012       6 Citations
  • Human leukocyte antigen profiles of latin american populations: differential admixture and its potential impact on hematopoietic stem cell transplantation. (Arrieta-Bolaños E, Madrigal JA, Shaw BE) Bone Marrow Res 2012;2012:136087 PMID: 23213535 PMCID: PMC3506882 12/06/2012    
  • Allogeneic transplantation: when is a mismatch better than a match? (Shaw BE, Nolan A) Biol Blood Marrow Transplant 2013 Jan;19(1):1-2 PMID: 23151492 SCOPUS ID: 2-s2.0-84871855518 11/16/2012    
  • NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome. (Mayor NP, Shaw BE, Madrigal JA, Marsh SG) Bone Marrow Res 2012;2012:180391 PMID: 23119165 PMCID: PMC3483648 11/03/2012    
  • Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. (Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL) Blood 2013 Jan 03;121(1):197-206 PMID: 23109243 PMCID: PMC3538330 SCOPUS ID: 2-s2.0-84872059501 10/31/2012       119 Citations
  • 'First do no harm': where do we stand on unrelated hematopoietic cell donor safety? (Lown RN, Shaw BE) Expert Rev Hematol 2012 Jun;5(3):249-52 PMID: 22780204 SCOPUS ID: 2-s2.0-84863797946 07/12/2012       6 Citations
  • Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). (Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso de Faveri G, Shaw BE, Schmidt AH, Fechter M, Madrigal A, Szer J, Aljurf MD, Weisdorf D, Horowitz MM, Greinix H, Niederwieser D, Gratwohl A, Kodera Y, Confer D) Bone Marrow Transplant 2013 Feb;48(2):220-5 PMID: 22773129 SCOPUS ID: 2-s2.0-84873482650 07/10/2012       41 Citations
  • Organ-specific management and supportive care in chronic graft-versus-host disease. (Dignan FL, Scarisbrick JJ, Cornish J, Clark A, Amrolia P, Jackson G, Mahendra P, Taylor PC, Shah P, Lightman S, Fortune F, Kibbler C, Andreyev J, Albanese A, Hadzic N, Potter MN, Shaw BE, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation) Br J Haematol 2012 Jul;158(1):62-78 PMID: 22533889 SCOPUS ID: 2-s2.0-84862254875 04/27/2012       74 Citations
  • Diagnosis and management of acute graft-versus-host disease. (Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation) Br J Haematol 2012 Jul;158(1):30-45 PMID: 22533831 SCOPUS ID: 2-s2.0-84862241567 04/27/2012       301 Citations
  • Diagnosis and management of chronic graft-versus-host disease. (Dignan FL, Amrolia P, Clark A, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation) Br J Haematol 2012 Jul;158(1):46-61 PMID: 22533811 SCOPUS ID: 2-s2.0-84862263770 04/27/2012       157 Citations
  • A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. (Hollenbach JA, Madbouly A, Gragert L, Vierra-Green C, Flesch S, Spellman S, Begovich A, Noreen H, Trachtenberg E, Williams T, Yu N, Shaw B, Fleischhauer K, Fernandez-Vina M, Maiers M) Immunogenetics 2012 Aug;64(8):559-69 PMID: 22526601 PMCID: PMC3395342 SCOPUS ID: 2-s2.0-84864282322 04/25/2012       54 Citations
  • Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. (Lown RN, Shaw BE) Bone Marrow Transplant 2013 Feb;48(2):210-9 PMID: 22484322 SCOPUS ID: 2-s2.0-84873432745 04/10/2012       59 Citations
  • Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. (Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW, International Histocompatibility Working Group in Hematopoietic Cell Transplantation) Lancet Oncol 2012 Apr;13(4):366-74 PMID: 22340965 PMCID: PMC3813000 SCOPUS ID: 2-s2.0-84859161258 02/22/2012       342 Citations
  • Transforming growth factor-β1 polymorphisms and the outcome of hematopoietic stem cell transplantation. (Arrieta-Bolaños E, Madrigal JA, Shaw BE) Int J Immunogenet 2012 Jun;39(3):192-202 PMID: 22284668 SCOPUS ID: 2-s2.0-84860920252 01/31/2012       5 Citations
  • Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. (Dignan FL, Greenblatt D, Cox M, Cavenagh J, Oakervee H, Apperley JF, Fielding AK, Pagliuca A, Mufti G, Raj K, Marks DI, Amrolia P, Peniket A, Medd P, Potter MN, Shaw BE, Scarisbrick JJ) Bone Marrow Transplant 2012 Jun;47(6):824-30 PMID: 21927038 SCOPUS ID: 2-s2.0-84862196374 09/20/2011       65 Citations
  • Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. (Anoop P, Shaw BE, Riley U, Ethell ME, Taj M, Lancaster DL, Atra A, Saso R, Littlewood S, Mohammed K, Davies F, Treleaven J, Morgan GJ, Potter MN) Hematology 2011 Jul;16(4):213-20 PMID: 21756537 SCOPUS ID: 2-s2.0-79960131848 07/16/2011       6 Citations
  • Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. (Shaw BE, Confer DL, Hwang WY, Pamphilon DH, Pulsipher MA) Haematologica 2011 Jul;96(7):942-7 PMID: 21719883 PMCID: PMC3128211 SCOPUS ID: 2-s2.0-79959924862 07/02/2011       70 Citations
  • Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. (Shaw BE, Apperley JF, Russell NH, Craddock C, Liakopoulou E, Potter MN, Wynn R, Gibson B, Pearce RM, Kirkland K, Lee J, Madrigal JA, Cook G, Byrne JL) Br J Haematol 2011 Apr;153(2):244-52 PMID: 21382020 SCOPUS ID: 2-s2.0-79953080775 03/09/2011       19 Citations
  • WMDA guidelines for subsequent donations following initial BM or PBSCs. (Confer DL, Shaw BE, Pamphilon DH, Clinical Working Group of the WMDA) Bone Marrow Transplant 2011 Nov;46(11):1409-12 PMID: 21297674 SCOPUS ID: 2-s2.0-80855156683 02/08/2011       17 Citations
  • An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. (Mohammed K, Dignan F, Ethell ME, Davies FE, Morgan GJ, Riley U, Evans S, Potter MN, Shaw BE) Leuk Lymphoma 2011 Feb;52(2):339-40 PMID: 21281242 SCOPUS ID: 2-s2.0-79551633669 02/02/2011    
  • Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. (Boo M, van Walraven SM, Chapman J, Lindberg B, Schmidt AH, Shaw BE, Switzer GE, Yang E, Egeland T, World Marrow Donor Association) Blood 2011 Jan 06;117(1):21-5 PMID: 20921337 SCOPUS ID: 2-s2.0-78650968837 10/06/2010       31 Citations
  • A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. (Kanga U, McWhinnie AJ, Mourya M, Shaw BE, Madrigal JA, Mehra NK) Tissue Antigens 2011 Jan;77(1):85-7 PMID: 20887382 SCOPUS ID: 2-s2.0-78650007320 10/05/2010       4 Citations
  • The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. (Shaw BE, Arguello R, Garcia-Sepulveda CA, Madrigal JA) Br J Haematol 2010 Aug;150(3):251-8 PMID: 20560963 SCOPUS ID: 2-s2.0-77954574035 06/22/2010       90 Citations
  • First do no harm. (Shaw BE) Blood 2010 Jun 17;115(24):4978-9 PMID: 20558623 SCOPUS ID: 2-s2.0-77956543300 06/19/2010       7 Citations
  • Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. (Duarte RF, Shaw BE, Marín P, Kottaridis P, Ortiz M, Morante C, Delgado J, Gayoso J, Goterriz R, Martínez-Chamorro C, Mateos-Mazón JJ, Ramírez C, de la Rubia J, Achtereekte H, Gandhi PJ, Douglas KW, Russell NH) Bone Marrow Transplant 2011 Jan;46(1):52-8 PMID: 20305700 SCOPUS ID: 2-s2.0-78651347616 03/23/2010       115 Citations
  • Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. (Hiwarkar P, Shaw BE, Tredger JM, Brown NW, Kulkarni S, Saso R, Evans S, Treleaven J, Davies FE, Ethell ME, Morgan GJ, Potter MN) Clin Transplant 2011;25(2):222-7 PMID: 20201951 SCOPUS ID: 2-s2.0-79953301752 03/06/2010       15 Citations
  • Unrelated hematopoietic stem cell donors as research subjects. (King RJ, Confer DL, Greinix HT, Halter J, Horowitz M, Schmidt AH, Costeas P, Shaw B, Egeland T, Ethics and Clinical Working Groups of World Marrow Donor Association) Bone Marrow Transplant 2011 Jan;46(1):10-3 PMID: 20190845 SCOPUS ID: 2-s2.0-78650976148 03/02/2010       14 Citations
  • Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. (Shaw BE, Ball L, Beksac M, Bengtsson M, Confer D, Diler S, Fechter M, Greinix H, Koh M, Lee S, Nicoloso-De-Faveri G, Philippe J, Pollichieni S, Pulsipher M, Schmidt A, Yang E, van Walraven AM, Clinical Working Group, Ethics Working Group of the WMDA) Bone Marrow Transplant 2010 May;45(5):832-8 PMID: 20173787 SCOPUS ID: 2-s2.0-77952428879 02/23/2010       51 Citations
  • Family donor care management: principles and recommendations. (van Walraven SM, Nicoloso-de Faveri G, Axdorph-Nygell UA, Douglas KW, Jones DA, Lee SJ, Pulsipher M, Ritchie L, Halter J, Shaw BE, WMDA Ethics and Clinical working groups) Bone Marrow Transplant 2010 Aug;45(8):1269-73 PMID: 20023708 SCOPUS ID: 2-s2.0-77955577789 12/22/2009       53 Citations
  • Human leukocyte antigen matching, compatibility testing and donor selection (Shaw BE) Hematopoietic Stem Cell Transplantation in Clinical Practice 2009:239-247 SCOPUS ID: 2-s2.0-84884452144 12/01/2009       5 Citations
  • Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. (Shaw BE, Mayor NP, Russell NH, Apperley JF, Clark RE, Cornish J, Darbyshire P, Ethell ME, Goldman JM, Little AM, Mackinnon S, Marks DI, Pagliuca A, Thomson K, Marsh SG, Madrigal JA) Leukemia 2010 Jan;24(1):58-65 PMID: 19924143 SCOPUS ID: 2-s2.0-74249117356 11/20/2009       87 Citations
  • Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. (Berro M, Mayor NP, Maldonado-Torres H, Cooke L, Kusminsky G, Marsh SG, Madrigal JA, Shaw BE) Haematologica 2010 Feb;95(2):276-83 PMID: 19713222 PMCID: PMC2817031 SCOPUS ID: 2-s2.0-76549092266 08/29/2009       8 Citations
  • Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. (Patel B, Kirkland KE, Szydlo R, Pearce RM, Clark RE, Craddock C, Liakopoulou E, Fielding AK, Mackinnon S, Olavarria E, Potter MN, Russell NH, Shaw BE, Cook G, Goldstone AH, Marks DI) Haematologica 2009 Oct;94(10):1399-406 PMID: 19648167 PMCID: PMC2754956 SCOPUS ID: 2-s2.0-70349804509 08/04/2009       29 Citations
  • Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? (Querol S, Mufti GJ, Marsh SG, Pagliuca A, Little AM, Shaw BE, Jeffery R, Garcia J, Goldman JM, Madrigal JA) Haematologica 2009 Apr;94(4):536-41 PMID: 19229051 PMCID: PMC2663617 SCOPUS ID: 2-s2.0-66349110894 02/21/2009       61 Citations
  • The impact of extramedullary disease at presentation on the outcome of myeloma. (Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, Potter MN, Ethell ME, Shaw BE, Morgan GJ) Leuk Lymphoma 2009 Feb;50(2):230-5 PMID: 19197724 SCOPUS ID: 2-s2.0-61349195971 02/07/2009       109 Citations
  • Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. (Tulpule S, Shaw BE, Makoni P, Little AM, Madrigal JA, Goldman JM) Bone Marrow Transplant 2009 Jul;44(2):129-30 PMID: 19151798 SCOPUS ID: 2-s2.0-68149120540 01/20/2009       23 Citations
  • Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. (Shaw BE, Veys P, Pagliuca A, Addada J, Cook G, Craddock CF, Gennery AR, Goldman J, Mackinnon S, Madrigal JA, Marks DI, Navarrete C, Potter MN, Querol S, Regan F, Russell NH, Hough RE) Bone Marrow Transplant 2009 Jul;44(1):7-12 PMID: 19139741 SCOPUS ID: 2-s2.0-67651124751 01/14/2009       16 Citations
  • An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. (Dignan FL, Evans SO, Ethell ME, Shaw BE, Davies FE, Dearden CE, Treleaven JG, Riley UB, Morgan GJ, Potter MN) Bone Marrow Transplant 2009 Jul;44(1):51-6 PMID: 19139735 SCOPUS ID: 2-s2.0-67651174360 01/14/2009       52 Citations
  • The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation. (Shaw BE) Int J Immunogenet 2008 Aug;35(4-5):367-74 PMID: 18976440 SCOPUS ID: 2-s2.0-52649103908 11/04/2008       11 Citations
  • Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. (Shaw BE, Mufti GJ, Mackinnon S, Cavenagh JD, Pearce RM, Towlson KE, Apperley JF, Chakraverty R, Craddock CF, Kazmi MA, Littlewood TJ, Milligan DW, Pagliuca A, Thomson KJ, Marks DI, Russell NH) Bone Marrow Transplant 2008 Dec;42(12):783-9 PMID: 18724393 SCOPUS ID: 2-s2.0-58149178882 08/30/2008       100 Citations
  • No impact of NOD2/CARD15 on outcome after SCT: a reply. (Mayor NP, Shaw BE, Madrigal JA, Marsh SG) Bone Marrow Transplant 2008 Dec;42(12):837-8 PMID: 18695658 SCOPUS ID: 2-s2.0-58149201269 08/13/2008       2 Citations
  • Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE. (Srikanth M, Davies FE, Wu P, Jenner MW, Ethell ME, Potter MN, Shaw BE, Saso RM, Dines S, Morgan GJ) Eur J Haematol 2008 Dec;81(6):432-6 PMID: 18691254 SCOPUS ID: 2-s2.0-56649121688 08/12/2008       22 Citations
  • Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia. (Tholouli E, Liakopoulou E, Greenfield HM, Shaw BE, Tauro S, Byrne JL, Dennis M, Burthem J, Lucas GS, Craddock C, Russell NH, Liu Yin JA) Br J Haematol 2008 Jun;142(2):318-20 PMID: 18492100 SCOPUS ID: 2-s2.0-47249105170 05/22/2008       7 Citations
  • Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma. (Ingram W, Devereux S, Das-Gupta EP, Russell NH, Haynes AP, Byrne JL, Shaw BE, McMillan A, Gonzalez J, Ho A, Mufti GJ, Pagliuca A) Br J Haematol 2008 Apr;141(2):235-43 PMID: 18318762 SCOPUS ID: 2-s2.0-40949125732 03/06/2008       43 Citations
  • In reply [6] (Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S, Marsh SGE) Journal of Clinical Oncology 10 January 2008;26(2):339 SCOPUS ID: 2-s2.0-38349173830 01/10/2008       1 Citation
  • Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. (Madrigal A, Shaw BE) Blood Cells Mol Dis 2008;40(1):40-3 PMID: 17964196 SCOPUS ID: 2-s2.0-36549001173 10/30/2007       13 Citations
  • Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant. (Shaw BE, Russell NH) Bone Marrow Transplant 2008 Mar;41(5):495-503 PMID: 17952130 SCOPUS ID: 2-s2.0-40749132553 10/24/2007       29 Citations
  • The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. (Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, Gratwohl A, Ringdén O, Marsh SG, Petersdorf EW) Blood 2007 Dec 15;110(13):4560-6 PMID: 17726164 SCOPUS ID: 2-s2.0-38349017549 08/30/2007       171 Citations
  • Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. (Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S, Marsh SG) J Clin Oncol 2007 Sep 20;25(27):4262-9 PMID: 17724347 SCOPUS ID: 2-s2.0-34948899807 08/29/2007       55 Citations
  • A novel technique for NOD2/CARD15 genotyping using PCR-SSP. (Mayor NP, Shaw BE, Keshav S, Madrigal JA, Marsh SG) J Immunol Methods 2007 Oct 31;327(1-2):82-7 PMID: 17719603 SCOPUS ID: 2-s2.0-34548816176 08/28/2007       2 Citations
  • Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab. (Das-Gupta EP, Russell NH, Shaw BE, Pearce RM, Byrne JL) Biol Blood Marrow Transplant 2007 Jun;13(6):724-33 PMID: 17531783 SCOPUS ID: 2-s2.0-34248679012 05/29/2007       11 Citations
  • The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants. (Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH) Biol Blood Marrow Transplant 2007 May;13(5):550-9 PMID: 17448914 SCOPUS ID: 2-s2.0-34247153887 04/24/2007       25 Citations
  • Clinical importance of HLA-DPB1 in haematopoietic cell transplantation. (Shaw BE, Gooley T, Madrigal JA, Malkki M, Marsh SG, Petersdorf EW) Tissue Antigens 2007 Apr;69 Suppl 1:36-41 PMID: 17445160 SCOPUS ID: 2-s2.0-34247245373 04/21/2007       17 Citations
  • 14thInternational HLA and Immunogenetics Workshop: report on hematopoietic cell transplantation. (Petersdorf E, Bardy P, Cambon-Thomsen A, Goulmy E, Hansen J, Schwarer A, Velardi A, IHWG HCT) Tissue Antigens 2007 Apr;69 Suppl 1:17-24 PMID: 17445157 SCOPUS ID: 2-s2.0-34247184314 04/21/2007       4 Citations
  • Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak. (Shaw BE, Boswell T, Byrne JL, Yates C, Russell NH) Bone Marrow Transplant 2007 May;39(10):623-9 PMID: 17384657 SCOPUS ID: 2-s2.0-34248168812 03/27/2007       29 Citations
  • Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with non-Hodgkin lymphoma and Hodgkin disease. (Bishton MJ, Lush RJ, Byrne JL, Russell NH, Shaw BE, Haynes AP) Br J Haematol 2007 Mar;136(5):752-61 PMID: 17313378 SCOPUS ID: 2-s2.0-33846959836 02/23/2007       22 Citations
  • Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005. (Duarte RF, Pamphilon D, Cornish J, Shaw BE, Samson D, Craddock C, Marks D, Mufti GJ, Powles RL, Apperley JF, Madrigal JA, Goldman JM) Bone Marrow Transplant 2006 May;37(10):901-8 PMID: 16670700 SCOPUS ID: 2-s2.0-33646903650 05/04/2006       4 Citations
  • The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. (Shaw BE, Russell NH, Devereux S, Das-Gupta E, Mackinnon S, Madrigal JA, Pagliuca A, Mufti GJ, Byrne JL) Haematologica 2005 Nov;90(11):1562-9 PMID: 16266905 SCOPUS ID: 2-s2.0-27844520392 11/04/2005       22 Citations
  • HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. (Shaw BE, Marsh SG, Mayor NP, Russell NH, Madrigal JA) Blood 2006 Feb 01;107(3):1220-6 PMID: 16234356 SCOPUS ID: 2-s2.0-31544468676 10/20/2005       97 Citations
  • Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. (Duarte RF, Delgado J, Shaw BE, Wrench DJ, Ethell M, Patch D, Dhillon AP, Mackinnon S, Potter MN, Quaglia AF) Biol Blood Marrow Transplant 2005 Oct;11(10):805-13 PMID: 16182181 SCOPUS ID: 2-s2.0-26044436267 09/27/2005       43 Citations
  • Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. (Kröger N, Shaw B, Iacobelli S, Zabelina T, Peggs K, Shimoni A, Nagler A, Binder T, Eiermann T, Madrigal A, Schwerdtfeger R, Kiehl M, Sayer HG, Beyer J, Bornhäuser M, Ayuk F, Zander AR, Marks DI, Clinical Trial Committee of the British Society of Blood and Marrow Transplantation and the German Cooperative Transplant Group) Br J Haematol 2005 Jun;129(5):631-43 PMID: 15916686 SCOPUS ID: 2-s2.0-20444463165 05/27/2005       106 Citations
  • Sequence of a novel HLA-A*0301 intronic variant (A*03010103). (Mayor NP, Cox ST, McWhinnie AJ, Argüello JR, Shaw BE, Little AM, Madrigal JA, Marsh SG) Tissue Antigens 2005 Jan;65(1):107-9 PMID: 15663748 SCOPUS ID: 2-s2.0-13144259649 01/25/2005       6 Citations
  • Scoring for HLA matching? A clinical test of HistoCheck. (Shaw BE, Barber LD, Madrigal JA, Cleaver S, Marsh SG) Bone Marrow Transplant 2004 Aug;34(4):367-8; author reply 369 PMID: 15195082 SCOPUS ID: 2-s2.0-4444282360 06/15/2004       17 Citations
  • Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. (Shaw BE, Maldonado H, Madrigal JA, Smith C, Petronzelli F, Mayor NP, Potter MN, Bodmer JG, Marsh SG) Tissue Antigens 2004 May;63(5):401-11 PMID: 15104672 SCOPUS ID: 2-s2.0-2442599990 04/24/2004       24 Citations
  • The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. (Shaw BE, Peggs K, Bird JM, Cavenagh J, Hunter A, Alejandro Madrigal J, Russell NH, Sirohi B, Towlson K, Williams CD, Marks DI, Clinical Trials Committee of the British Society of Blood and Marrow Transplantation) Br J Haematol 2003 Dec;123(5):886-95 PMID: 14632780 SCOPUS ID: 2-s2.0-10744222146 11/25/2003       24 Citations
  • The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. (Shaw BE, Potter MN, Mayor NP, Pay AL, Smith C, Goldman JM, Prentice HG, Marsh SG, Madrigal JA) Bone Marrow Transplant 2003 Jun;31(11):1001-8 PMID: 12774051 SCOPUS ID: 2-s2.0-0038686000 05/30/2003       58 Citations
  • Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. (Shaw B, Mehta AB) Clin Lab Haematol 2002 Dec;24(6):385-7 PMID: 12452820 SCOPUS ID: 2-s2.0-0036887292 11/28/2002       22 Citations
  • Improving the outcome of unrelated donor stem cell transplantation by molecular matching. (Shaw BE, Madrigal JA, Potter M) Blood Rev 2001 Dec;15(4):167-74 PMID: 11792117 SCOPUS ID: 2-s2.0-0035736706 01/17/2002       20 Citations
  • Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy. (Shaw BE, Perry D, Hoffbrand AV) Leuk Lymphoma 2001 Jun;42(1-2):221-3 PMID: 11699211 SCOPUS ID: 2-s2.0-0034925675 11/09/2001       11 Citations
  • Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. (Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C, Neumeister P, Finazzi G, Iacobelli M, Bowyer K, Prentice HG, Barbui T) Br J Haematol 2000 Dec;111(4):1122-9 PMID: 11167751 SCOPUS ID: 2-s2.0-20244365292 02/13/2001       182 Citations
  • Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation. (Paterson PJ, Marshall SR, Shaw B, Kendra JR, Ethel M, Kibbler CC, Prentice HG, Potter M) Bone Marrow Transplant 2000 Sep;26(6):701-3 PMID: 11041574 SCOPUS ID: 2-s2.0-0033794828 10/21/2000       8 Citations
  • Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression. (Somers LJ, Shaw B, Lyn BE, McMillan AM, Mahendra P) Clin Lab Haematol 1998 Jun;20(3):189-90 PMID: 9681237 SCOPUS ID: 2-s2.0-0031810257 07/29/1998       5 Citations
    • Last update: 09/10/2026